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The  aim  of  this  study  was  to  explore  the  functions  of  T-type calcium channels, and their 
possible role in neuronal stem cells migration. The role of T-type calcium channel in mature 
brain is known to be in producing electroencephalographic oscillations. This action in turn is 
the key factor in some neuronal physiological and pathophysiological functions, like non-REM 
sleep, memory, learning and absence epilepsy. In addition, T-type calcium channels have 
peripheral actions, but this study concerns on its neuronal functions. This low-voltage 
activated channels functions in neurogenesis is  less  known than its  role  in  mature brain.  It  is  
known to promote neuronal proliferation and differentiation, but what comes to its possible 
actions in neuronal migration, is poorly studied. This study shows some evidence of T-type 
calcium channel taking part in neuronal migration in mice embryonic subventricular zones 
progenitor cells. Selective T-type antagonists, ethosuximide, nickelchloride and a scorpion 
peptide toxin kurtoxin, decreased the rate of migration in differentiating progenitor cells.  
 
This study consists of a literature review and an experimental part. Another aim of this study is 
to consider an alternative approach to stem cell therapies based on invasive transplantation of 
the  cells.  This  other  attempt  is  non-invasive manipulating of endogenous stem cells to 
proliferate and migrate to the injured or depleted area in the brain, differentiate into a desired 
phenotype and stop their division after they have completed their mission. Non-invasive 
altering of the stem cells is awaiting pharmacological solutions to resolve the problems being 
faced in this effort. There are some non-invasive therapies already being used successfully to 
cure pathological conditions such as spinal cord injury. These methods could be used as well 
in stem cell based therapies in the treatment of neurodegenerative diseases and brain injuries. 
These methods are still in the beginning of their way and lacking the full understanding of the 
key factors that affect neuronal development. These factors include some important 
endogenous inducing and inhibiting substances. One of the most important inducing 
substances is calcium ion regulating a variety of events in neurogenesis. T-type calcium 
channel, as being widely expressed during early brain development, and decaying by neuronal 
maturation, might have a pivotal role in conducting progenitor cells. 
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Tämän tutkimuksen tarkoitus oli tutkia T-tyypin kalsiumkanavan toimintaa ja sen mahdollista roolia 
neuronaalisten kantasolujen migraatiossa. T-tyypin kalsiumkanavan tehtävän kehittyneissä aivoissa 
tiedetään olevan elektroenkefalografisten oskillaatioiden tuottaminen. Nämä taas ovat eräiden 
fysiologisten ja patofysiologisten tapahtumien säätelyssä avainasemassa. Tällaisia tapahtumia ovat uni, 
muisti, oppiminen ja epileptiset poissaolokohtaukset. Näiden lisäksi T-tyypin kalsiumkanavalla on myös 
periferaalisia vaikutuksia, mutta tämä tutkielma keskittyy sen neuronaalisiin toimintoihin. Tämän 
matalan jännitteen säätelemän kanavan toiminta neurogeneesin aikana on vähemmän tutkittua ja 
tunnettua kuin sen vaikutukset kehittyneissä aivoissa. T-tyypin kalsiumkanavan tiedetään edistävän 
kantasolujen proliferaatiota ja erilaistumista neurogeneesiksen aikana, mutta vaikutukset niiden 
migraatioon ovat vähemmän tunnetut. Tämä tutkimus näyttää T-tyypin kalsiumkanavan todennäköisesti 
osallistuvan neuronaaliseen migraatioon hiiren alkion subventrikkeli alueelta eristetyillä kanta- tai 
progeniittorisoluilla tehdyissä kokeissa.  Selektiiviset T-tyypin kalsiumkanavan antagonistit, 
etosuksimidi, nikkeli ja skorpionitoksiini, kurtoxin hidastivat migraatiota erilaistuvissa 
progeniittorisoluissa. 
Tämä tutkimus koostuu kirjallisuuskatsauksesta ja kokeellisesta osasta. Tämän tutkimuksen toinen 
tarkoitus oli esitellä vaihtoehtoinen lähestymistapa invasiiviselle kantasoluterapialle, joka vaatii 
kantasolujen viljelyä ja siirtämistä ihmiseen. Tämä toinen tapa on endogeenisten kantasolujen ei-
invasiivinen stimulointi, jolla ne saadaan migratoitumaan kohdekudokseen, erilaistumaan siellä ja 
tehtävänsä suoritettuaan lopettamaan jakaantumisen. Non-invasiivinen kantasoluterapia on vasta tiensä 
alussa, ja tarvitsee farmakologista osaamista kehittyäkseen. Joitain onnistuneita ei-invasiivisia hoitoja 
on jo tehty selkärangan vaurioiden korjaamisessa. Vastaavanlaisia menetelmiä voitaisiin käyttää myös 
keskushermoston vaurioiden ja neurodegeneratiivisten sairauksien hoidossa. Näiden menetelmien 
kehittäminen vaatii endogeenisten kantasoluja inhiboivien ja indusoivien mekanismien tuntemista. Yksi 
tärkeä kantasolujen erilaistumista stimuloiva tekijä on kalsiumioni. Jänniteherkät kalsiumkanavat 
osallistuvat kaikkiin neurogeneesiksen eri vaiheisiin. T-tyypin kalsiumkanava, joka ekspressoituu 
suuressa määrin keskushermoston kehityksen alkuvaiheessa ja vähenee neuronaalisen kehityksen 
edetessä, saattaa olla oleellisessa asemassa progeniittorisolujen ohjaamisessa. 
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LITERATURE PART 
 
 
1. Introduction 
 
Until the beginning of last century, the cells of the central nervous system were thought 
to be incapable of regeneration (Stahnisch and Nitsch, 2002).  In 1928, a Nobel-prized 
researcher Santiago Ramón y Cajal wrote: “In adult centres, the nerve paths are 
something fixed, ended, immobile. Everything may die, nothing may be regenerated” 
(Ramón y Cajal, 1928). Over the last decade various studies have shown that there is 
plasticity and regeneration in the adult brain (Cotman and Nieto-Sampedro, 1985). 
These findings give rise to a possibility of regenerative cell therapy. 
The strategies to investigate novel stem cell therapies begin with understanding their 
mechanisms of division, proliferation, migration and differentiation of neuronal stem 
cells (Morest and Silver, 2003). These events can be understood by studying the key 
modulators of these events (Barkho et al, 2006). One important factor in neurogenesis is 
genes dictating the fate of cells on their way differentiating from stem cells into a 
variety of mature cells. One could conclude that the genetics is the main thing 
controlling this scenario. Nevertheless, neuronal differentiation is influenced by several 
signaling molecules in addition to the control of gene expression (Greenberg et al, 
1992).  It is proven in a number of studies that some environmental factors also can 
affect stem cells life cycle (Schofield, 1978; Fuchs et al, 2004; Barkho et al, 2006). This 
study concentrates on the latter factor. 
Environmental factors can be of different biochemical groups containing growth factors, 
neurotransmitters and some external factors including toxic compounds and 
pharmacological substances, for example (Emerit and Riad, 1992; Nguyen et al, 2001; 
Hagg, 2005). Elevated intracellular calcium is also a typical trigger of plastic changes in 
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neurons (Spitzer et al, 2004; D’Ascenzo et al, 2006; Deisseroth et al, 2004). Changes in 
calcium concentration may thus represent a common target for factors and signals that  
regulate neuronal progenitor cells differentiation and acquisition of specific neuronal 
phenotypes. 
When investigating the effect of intracellular calcium in this study, the issue of interest 
is  in  particular  the  neuronal  T-type  calcium  channel.  This  is  partly  due  to  the  lack  of  
studies of this type in this field of research. More precisely, the aim of this study is to 
explore the T-type calcium channels role in neuronal migration. One of the most poorly 
studied events in stem cells differentiation is their migration (Morest and Silver, 2003). 
Some  essential  questions  remain  unanswered:  What  makes  them  move?  How  do  they  
know where to go? Why do some of them stay close to the sphere and others migrate far 
away from the beginning?  
It is evident to study the function of T-type calcium channel when exploring its role in 
stem cells migration. While studying the physiological function of the T-type calcium 
channel, we gain some important information on its action, which might be useful also 
in designing other therapies than those based on stem cells. Yet, these theories need to 
be confirmed with studies on the relevant cell lines in question. 
The capacity of adult neurons to regenerate offers intriguing possibilities which are 
nowadays being better understood, yet still beyond the reach of healthcare.  
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2. Neural progenitor cells 
 
During the early brain development in the vertebrate embryo, a structure called neural 
plate is formed (Spemann and Mangold, 1924). That consists of a thick epithelium of 
cells,  which  transforms into  a  tube  called  the  neural  tube.  This  neural  tube  is  an  early  
development  stage  of  the  brain  and  spinal  cord.  The  cells  of  this  neural  tube  with  the  
capacity to differentiate into neurons and glial cells are known as neural precursor cells 
(Sauer, 1935). These precursor cells are often reffered to as dividing neural stem cells 
(NSC). The neural stem cells give rise to neurons, astrocytes and oligodendroglial cells 
(Alvarez-Buylla and Lim, 2004). Neural progenitor cells form a heterogeneous 
population of glial and neural cells with varying multipotency. Differentiation happens 
gradually by the cells dividing and giving birth to new daughter cells, while some of 
them undergo an apoptotic cell death. The line between a stem cell and a differentiated 
cell is rather obscure. The difference between a stem cell and a progenitor cell is 
described with terms omnipotency and pluripotency. What then actually is a stem cell? 
There is a precise definition for a stem cell. The common features of stem cells are the 
ability of self-renewal by dividing and multi-potency to differentiate into any kind of a 
cell  in  the  body,  i.e.,  is  omnipotent.  This  concerns  a  limited  group of  progenitor  cells,  
which have lost some of their multi-potency, and have adapted features of a tissue type, 
i.e., is pluripotent. A neural progenitor cell or a precursor cell might differentiate as well 
into  a  neuron  as  a  glial  cell,  while  a  stem  cell  has  the  ability  to  differentiate  into  any  
kind of a cell in the body. This makes the term progenitor cell useful concerning a large 
group of cells during their differentiation. 
Distinguishing the states of differentiation is not problematic just because of the 
complexity of biology, but also because of the definitions being arguable (Morest and 
Silver, 2003). The often used term “glia” has lost its previous meaning of being a 
hyperonym for the glial cells. This is because of the different kind of glial cells can have 
very  little  in  common with  each  other.  Even  less  useful  it  is  as  a  definition  for  a  non-
neuronal cell, since the neurons arise from the same progenitors and change constantly 
their phenotype during the differentiation. The term “glial” is more often used to 
describe the glial nature of the cells retaining the traditional glial functions as being the 
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supporting cells and also those that maintaining the capacity to differentiate (Kriegstein 
and Alvarez-Buylla, 2009).     
As the multipotent neural precursor cells divide and differentiate, they generate an event 
known as neurogenesis which occurs both in the developing, and in the adult brain 
(Imayoshi et al, 2008). Neurogenesis in mammals begins with the induction of the 
neuroectoderm, which forms the neural plate at embryonic day 7.5 in mice (Temple, 
2001). That gives rise to the neural tube (E8.5 in mice). These structures are made up by 
the neuroepithelial progenitors, which are a complex and heterogenous population 
(Boulder, 1970). This is followed by a progressive thickening of the cortex, and 
neuroepithelial progenitors obtaining features associated with radial glial cells (Choi 
and Lapham, 1978). The continuous dividing of these radial glial cells leads to a 
dynamic formation of intermediate progenitor cells (IPCs) producing mature neurons 
and such glial cell subtypes as astrocytes and oligodendrocytes (Haubensak et al, 2004). 
The same process can be seen also as a balance between symmetrical and asymmetrical 
division (Alvarez-Buylla, and Lim, 2004). Radial glial cells divide mostly 
asymmetrically, while the IPCs divide symmetrically. Symmetrical division is the cell’s 
way of self-renewing by making similar daughter cells. Asymmetrical cell division 
produces fate-determined differentiated cells. Symmetrical division takes place in the 
beginning of neurogenesis. As the cells divide, they form a symmetrical round sphere, 
called neurosphere. The cells forming neurospheres happens in vitro. Neurosphere is a 
free floating cell aggregate (Reynolds and Weiss, 1992). It is possible to derive pure 
NSC lines that exhibit features of neurogenic radial glia (RG) progenitors (Conti and 
Cattaneo, 2005). In vitro they form neurospheres in a two-dimensional growth 
environment by symmetrical division. They can be considered as tripotent as they can 
give rise to neurons, astrocytes and oligodendrocytes. The extrinsic factors fibroblast 
growth factor 2 (FGF-2) and epidermal growth factor (EGF) are proven to be sufficient 
for derivation and continuous expansion by symmetrical division of pure cultures of 
neural stem cells. 
At  the  end  of  a  developmental  period  of  neuroepithelial  division,  the  radial  glial  cells  
lose their ventricular attachment, proliferate and start migrating towards the cortical 
plate (Morest 1970; Choi and Lapham, 1978). In mammals, most radial glial cells 
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transform into astrocytes. The exact timings of division, proliferation, migration and 
differentiation are not specified yet, and these developmental phases are dynamic, 
overlapping processes (Kriegstein and Alvarez-Buylla, 2009), rather than chronological 
and rigid events, as it can be seen in picture 1. 
 
 
 
Picture 1 Lineage tree of NSCs (Adapted and modified from Kriegstein and Alvarez-Buylla, 
2009) 
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2.1 Postnatal stem cells 
 
Before 1962 it was believed that after birth the CNS was structurally stable, with no 
neurogenesis happening in the postnatal brain. After publication of a study using the 
newly introduced methods of 3H-thymidine autoradiography challenged this view 
(Altman, 1962). 3H-thymidine is taken up by cells undergoing DNA synthesis in 
preparation for mitosis, and thus can be used as a marker for proliferating cells and their 
progeny. 
Neurogenesis continues in the adult hippocampus, specifically in the subventricular 
zone (SVZ) in the walls of the lateral ventricles (Gage, 2000). In adult rodents the 
neurogenesis occurs mainly in the hippocampal subgranular zone (SGZ) and in the 
subventricular zone (SVZ), whereas in man it is restricted to SVZ. The young neurons 
from this area migrate to the olfactory bulb where they continually replace local 
interneurons (Imayoshi et al, 2008). 
Adult neurogenesis happens also in normal conditions at some level, and is being 
induced in the cases of brain injury or degeneration (Kriegstein and Alvarez-Buylla, 
2009). There is evidence of induced adult neurogenesis under certain circumstances. It 
can be activated by stress (Gould et al, 1997). Social stress in tree shrews is an animal 
model  of  depression  (Raab  and  Storz,  1976).  Both  social  stress  and  treatment  with  
NMDA- receptor agonist MK-801 induced cell division in dentate gyrus of 
hippocampus of a tree shrew, and these cells migrate into the hippocampal granule cell 
layer (Gould et al, 1997). It was suggested that these results could be extrapolated to 
other mammalian species as well. 
Also enriched environment induced neurogenesis in mice dentate gyrus of hippocampus 
and enlarged hippocampal granule cell layer (Kempermann et al, 1997). An enriched 
environment is an experimental setting that differs from standard laboratory housing 
conditions (Praag et al, 2000). It contains much more stimulus and exercise than that of 
a control group. The stimulus can be a larger group of animals in larger cages with 
varying and complex environment with for example tunnels and toys. The 
circumstances are changed frequently. Although increasing neurogenesis in mice, this 
study also questioned the beneficial effect of an enriched environment. There are many 
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factors that affect this method. Some of them are motivation and voluntary of the animal 
to interact with the environment. This method is questionable also for another reason. It 
cannot be said whether the enriched environment actually causes stress to the animal, 
and thereby induces neurogenesis, stimulates CNS cells and increases neuronal 
connections.  More  evidence  of  the  effect  of  stimulation  is  gained  with  an  opposite  
method. It is known that sensory deprivation withers neuronal networks. 
Several forms of brain damage are shown to trigger neurogenesis in the postnatal brain 
(Tanaka et al, 2004). Seizure and stroke are shown to promote neurogenesis in the 
dentate gyrus. In an adult gerbil animal model the three steps of neurogenesis were 
detected with chemical markers after ischemia (Iwai et al, 2002). Three steps of 
neurogenesis, proliferation, migration and differentiation were elucidated with 
bromodeoxyuridine (BrdU), highly polysialylated neural cell adhesion molecule (PSA-
NCAM), and neuronal nuclear antigen (NeuN) and glial fibrillary acidic protein 
(GFAP), respectively. A peak in cell number was detected 10 days after ischemia, with 
a seven-fold increase in BrdU-labeled cells and a three-fold increase in PSA-NCAM-
positive cells in SGZ. The cell number of all markers increased gradually, and the 
BrdU- labeled cells with NeuN continued dividing in GCL (granule cell layer) until 2 
months after ischemia. These results demonstrate that neural stem cell proliferation 
begins in SGZ and continues with the cells migrating into the GCL where they 
differentiate into mature neurons.  It should be noted at this point, that in man the 
proliferation occurs mainly in the SVZ (Gage, 2000). This study also shows that brain 
damage in the form of ischemia induces neurogenesis. 
Another study supports the findings described above. In a chemoconvulsant model of 
temporal lobe epilepsy the contribution of newly differentiated dentate granule cells was 
detected (Parent et al, 1997). Pilocarpine-induced status epilepticus in rats was followed 
by neurogenesis. BrdU- labeled cells had colocalized from SGZ to granular cell layer, 
GCL. The BrdU-labeled cells in the SGZ increased up to 13 days and were found from 
granular cell layer 56 days after the seizure. Also the ratio between the BrdU- labeled 
cells in SGZ and GCL gradually changed as an increase in the cells found in GCL. This 
indicates the level of migration being higher than in the control group. The cells that 
had migrated into GCL also expressed neuronal markers. 
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The role of adult  neurogenesis seems to be the replacement of neurons.  This still  does 
not explain why this takes place in varying conditions.  For an unknown reason, 
neurogenesis does not happen decently in neurodegenerative diseases, and not always in 
the case of brain injury,  not at  least  at  a sufficient level that  is  needed for the brain to 
function  normally.  To  be  optimistic,  the  evidence  of  adult  neurogenesis  gives  hope  of  
non-invasive stem cell treatment based on stimulation of the endogenous repair 
processes. 
 
2.2. Stem cell therapies in neuronal regeneration 
 
The therapeutic interest of the stem cells is their ability to generate cells and tissues to 
replace those that may have been lost due to disease or injury (Purves et al, 2008). 
Although  there  has  been  some  promising  work  done  in  mice   and  some  other  
experimental animals, there is no clinically validated use of stem cells for human 
therapeutic applications in the nervous system. The main problem is to introduce stem 
cells into mature tissue and control their division and stop it when needed. 
Sources of used stem cell lines should be validated depending on the purpose (Hess and 
Borlongan, 2008). There is a significant difference between the mature somatic stem 
cells and embryonic stem cells (ES cells). They both have the potential for infinite self-
renewal, but the ES cells can give rise to all tissue and cell types of the organism, while 
the somatic stem cells generate only tissue-specific cell types. Mesenchymal stem cells, 
MSCs, are multipotent, embryonic stem cells derived from the mesoderm. Confusing, 
yet, is a finding that bone marrow cells can adopt a neuronal phenotype when grown on 
a soft matrice, and a bone phenotype while on a hard matrice (Engler et al, 2006) and 
are also termed as MSC, marrow stromal cells. In addition, these cells can differentiate 
to haematopoietic stem cells (Spangrude et al, 1988). Olfactory receptor neurons that 
are replaced throughout life in mammals send axonal projections into the olfactory bulb. 
The cell that ensheaths these axons, known as an olfactory ensheathing cell (OEC), has 
same characteristics as astrocytes (Doucette, 1984). Also adult and embryonic neural 
stem cells derived from hippocampal areas are used in treatment of neural diseases. The 
best alternative for a stem cell source would be the patient’s own cells. That would 
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avoid the problems faced with the immune system. On the other hand, in the case of 
disease having a genetic background, there is still a risk of the same diseased DNA 
being imported to the body.  
Neural stem cells possess therapeutic potential because of their ability to migrate 
towards distant areas of injury (Aboody et al, 2000; Benedetti et al, 2000; Herrlinger, et 
al, 2000). More amazingly, they can migrate to CNS also from the peripheral tissues. 
This is a huge advantage, considering the problems of intra-cerebral injecting.  In a rat 
Parkinson’s disease animal model neural progenitor cells can survive and differentiate 
into neurons and glial cells (Svendsen et al, 1996). 
There are some strategies in stem cell therapy that have been used to cure neurological 
diseases and injuries in humans with more or less success. These strategies can be 
divided into invasive and non-invasive methods (Barreiro-Iglesias, 2010). Invasive 
methods can be carried out by delivering the cells intracerebrally, or by an intravenous 
or intra-arterial route (Hess and Borlongan, 2008). Non-invasive methods include 
endogenous stem cells mobilization approaches in which stem and progenitor cells are 
mobilized by delivering into the brain cytokines such as granulocyte colony stimulatory 
factor (GCSF) or chemokines such as SDF-1; trophic and growth factor support, such as 
brain-derived neurotrophic factor (BDNF) or glial-derived neurotrophic factor (GDNF), 
to list some examples. 
 
2.2.1 Problems with invasive therapies 
 
Problems with current invasive methods have kept stem cell therapies out of the reach 
of healthcare. Of great clinical significance would be a solution of a scalable and easily 
commercialized therapy (Hess and Borlongan, 2008). 
All invasive, cell based therapies involve in vitro culturing and manipulation of the stem 
cells before transplantation into the patient (Barreiro-Iglesias, 2010). Other 
disadvantages include the potential for teratoma formation, aberrant reprogramming and 
the presence of transgenes in cell populations. 
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Mesenchymal stem cells have gained some clinical interest because of their potential 
use in regenerative medicine and tissue engineering thus MSCs safety in clinical use 
remains questionable (Yu et al, 2008). In a study MSCs derived from human adipose 
tissues together with tumor cells were transplanted subcutaneously or intracranially into 
nude mice to observe tumor outgrowth. The results indicated that human adipose stem 
cells with tumor cell lines promoted tumor growth in nude mice. These findings indicate 
that MSCs could favor tumor growth in vivo (Yu et al, 2008). Some studies show that 
also the putative epithelial progenitor cells derived from bone marrow also contributes 
to tumor angiogenesis (Asahara et al, 1999; Poulsom et al, 2002; Rabitti, 2004). Once 
introduced to the body, the cell division is uncontrolled. 
 
Immunity is another thing to consider. In the worst case, the transplant will be rejected 
by the host immune system (Griffin et al, 2010). If succeeded, a life-long 
immunosuppressing therapy might still be needed. Optimistically there is some 
promising  work  done  with  allogenic  mesenchymal  stem  cells.  MSCs  are  shown  to  
induce immune system by stimulating multiple targets in the immune system including 
T-cells (Batten et al, 2001) and even in the absence of additive immunosuppressive 
therapy (Kahan, 2003). 
 
In addition to the problems described above, one essential challenge is to control the 
differentiation of transplanted stem cells into a desired phenotype. Transplantation of 
human embryonic stem cell- derived neural progenitors into rodent striatum led to 
partial behavioural recovery in a rodent Parkinson’s disease model (Ben-Hur et al, 
2004). In this experiment the cells did not acquire a full dopaminergic phenotype in the 
rodent brain which made the researchers conclude that the differentiation into neurons 
should take place before transplantation. In a 1 methyl-4-phenyl-1,2,3,6-
tetrahydropyridine (MPTP) primate model of Parkinson’s disease, transplantation of 
embryonic stem cell-derived enriched dopaminergic neurons resulted in survival of less 
than 1 % of transplanted neurons during a 14 weeks period (Takagi et al, 2005). 
 
However, the ethical questions remain in what comes to using of fetal and embryonic 
stem cells. Two randomized controlled trials using dopaminergic neurons from aborted 
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fetuses failed to show much benefit and also there were reported troublesome 
dyskinesias in both studies (Freed et al, 2001). These poor results combined with ethical 
concerns led to abandonment of this approach. Ethics upon the use of embryos depend a 
lot on the source of embryonic cell used. Currently, there are three main sources of 
embryonic stem cells:  already existing embryonic stem cell lines, embryos that are left 
unused after in vitro fertilization procedures and embryos created by means of somatic 
cell nuclear transfer technique (cloning) (Hug, 2004). Acceptance of these methods is 
variable, but the most commonly accepted source is already existing stem cell lines. 
 
The  outcome  of  these  problems  is  that  the  stem  cell  therapies  current  situation  is  
desperate. Although succeeding in culturing stem cells from the donor being the same 
as receiver, and thereby avoiding ethical and immunity problems, differentiating the 
cells into a desired phenotype and transplanting them into the body, several problems 
still remain. Those include the stem cells survival, differentiation and not turning into 
tumorgenic cells. In addition to all this, a cost-effective method must be developed 
before implementation into healthcare.  
 
2.2.2 Possibilities in non-invasive therapies 
 
The knowledge about adult neurogenesis and the factors inducing it offer us a 
possibility to create strategies of manipulating endogenous mechanisms of regeneration. 
First  thing  to  find  out  before  that  can  happen  is  to  examine  the  key  factors  that  affect  
this phenomenon. 
 
The neuronal stem cells are able to migrate towards areas of injury mediated by some 
agents as a chemokine called SDF-1 (stromal cell-derived factor-1) that is up-regulated 
in astrocytes and endothelial cells in injured tissue (Imitola et al, 2004) although this 
does not happen in uninjured tissue (Abbott et al, 2004). This substance is classified as 
inflammatory mediators (Martino and Pluchino, 2006), and other agents of this group 
are cytokines as rantes (Owens et al, 2005) other chemokines as fractalkine, also 
including some interleukins as IL-1? and IL-6 (Aloisi et al, 2006). Inflammation is 
associated in many pathological conditions, such as cancer and some neurodegenerative 
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diseases.  In  addition  to  migration,  these  factors  induce  cell  proliferation  and  
differentiation. Conducting the differentiation into dopaminergic neurons is partly 
affected by IL-1? (Storch et al, 2001).  
 
Growth factors are reported to conduct differentiation, proliferation and survival of 
neuronal progenitor cells (Martino and Pluchino, 2006). Glial-derived neurotrophic 
factor, GDNF, has shown neuroprotective and regenerative effects in a variety of animal 
Parkinson’s disease models (Björklund et al, 1997; Behrstock et al, 2006). In human 
clinical studies this promising approach has failed due to significant side-effects 
(Kordower et al, 1999; Nutt et al, 2003). Brain-derived neurotrophic factor, BDNF, is 
reported to enhance the differentiation (Ahmed et al, 1995), but not in that specific way 
as  GDNF.  Of  a  great  significance  to  laboratory  in vitro propagation of neuronal 
precursors has been a discovery, that epidermal growth factor (EGF) and fibroblast 
growth factor (FGF-2) stimulate the division of embryonic or adult CNS precursors 
(Ciccolini and Svendsen, 1998). This is evident for maintaining a continuous 
undifferentiated cell line where a single cell divides and forms a cluster called 
neurosphere. Leukemia inhibitory factor (LIF) is also used for the same purpose 
(Tropepe et al, 2001). Other growth factors taking part in neurogenesis are ciliary 
neurotrophic factor, CNTF, erythropoietin, platelet-derived growth factor, PDGF, 
transforming growth factor-?, TGF-? and vascular endothelial growth factor-?, VEGF-? 
(Martino and Pluchino, 2006). 
 
Some therapeutic strategies have already been investigated with trophic factors and 
cytokines to promote endogenous SVZ cell mobilization. They have been delivered to 
the brain either by viral vectors, infusions or via intranasal administration (Cayre et al, 
2009). In Parkinson disease mouse models neuronal progenitors have been attracted 
toward the lesion with GDNF or TGF? infusion, and improved functional deficits. This 
has raised hope for the development of new strategies in neurodegenerative diseases, 
but  clinical  trials  have  failed  so  far.  Also  an  infusion  of  FGF-2  and  EGF  has  had  the  
same effect in increasing directed migration toward the lesioned area (Winner et al, 
2008).  EGF is  also  shown to  be  useful  in  other  studies,  but  presents  some limitations.  
One of them is that it favors astrocytic differentiation over neuronal differentiation, 
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which may not have beneficial effects. The other concern is that it may facilitate the 
development of tumors. BDNF is another growth factor that has properties for 
progenitor cell mobilization. An injection of adenovirus expressing BDNF triggers 
increased olfactory neurogenesis and induces the migration of newborn neurons from 
SVZ to otherwise non-neurogenic regions (Benraiss et al, 2001). The hematopoietic 
cytokine erythropoietin (EPO) injection after a stroke increases the levels of VEGF and 
BDNF, which in turn leads to angiogenesis, neurogenesis and functional recovery 
(Wang et al, 2007).  
 
The specific stem cell regulators form one group of the mediators in neurogenesis 
(Martino and Pluchino, 2006). Two major stem cell fate regulators are Sonic hedgehog, 
Shh and Notch-signaling membrane protein. Other regulators of this group are bone 
morphogenetic protein 4 (BMP 4), noggin-polypeptide and an extracellular matrix 
protein called tenascin C (Martino and Pluchino, 2006). Sonic hedgehog is a 
glycoprotein molecule that plays a critical role in the proliferation of endogenous neural 
precursor cells (Alvarez-Buylla et al, 2001). Administration of an intravenous hedgehog 
agonist induced endogenous cell proliferation after contusion in the adult rat spinal cord 
(Bambakidis et al, 2009). No side-effects were detected in the animals during the 
experiment. The data gained in study also provides evidence that direct injection of the 
agonist into the CNS is unnecessary to induce a proliferative response. Another study 
corroborates the effect of an Shh agonist. Intraperitoneal injection of cyclopamine, a 
sonic hedgehog antagonist, reduces ventricular proliferation and motor neuron 
regeneration in zebrafish (Reimer et al, 2009). Furthermore, one  study  shows,  that  
activation of the Shh signaling pathway, using an orally administered Hh agonist, leads 
to proliferation of endogenous progenitor cells (Machold et al, 2003). Notch signaling 
regulates stem cell numbers both in vitro and in vivo (Androutsellis-Theotokis et al, 
2006). It activates expression of genes hairy and enhancer of split 3 (Hes3) as well as 
the  expression  of  sonic  hedgehog,  by  activating  cytoplasmic  signals  that  lead  to  stem  
cell expansion. Hypoxia-inducible factor 1 is shown to be crucial for embryonic stem 
cell survival (Iyer et al, 1998). As a homeostatic O2- regulator, it activates in response to 
physiologically relevant levels of hypoxia. It is activated also in progenitor cells niche. 
A related finding is that the number of progenitor cells in spinal cord increases in 
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response to injury or physical activity in adult rats (Cizkova et al, 2009). Both of these 
states represent a condition where hypoxia occurs. 
 
Some common inductive neurotransmitters such as acetylcholine, glutamate and 
receptor activating ions play also an important role in differentiation (Kärkkäinen et al, 
2009). Neural progenitor cells show metabotoropic responses (Ca2+ -discharge from 
intracellular stores) to glutamate, norepinephrine, acetylcholine and ATP during the first 
days of in vitro differentiation (Kärkkäinen et al, 2009). One of the most important 
inductive signals is retinoic acid that activates a class of transcription factors that 
modulate the gene expression. That is interesting regarding the fact that retinoic acid is 
also  a  teratogen.  Not  all  the  signals  are  inductive,  to  maintain  the  regulation  and  
homeostasis, there are also some inhibitory signals, such as noggin and chordin, 
endogenous antagonists that modulate signaling via the TGF-? family. 
A variety of studies suggest that environmental enrichment and exercise enhance brain 
plasticity. In physiological conditions, running and enrichment increase the levels of 
growth factors such as BDNF, IGF (insulin-like growth factor), NGF (neuronal growth 
factor) and FGF-2 (Gomez-Pinilla et al, 1997) and dentate gyrus (DG) neurogenesis 
(Kempermann et al, 1997). Environmental enrichment in clinical trials is much alike 
compared to the animal experiments. It includes physical and cognitive exercise and 
completing of demanding tasks in an environment that changes every day. Enrichment 
and exercise can be considered as a complementary therapy for brain repair. 
 
These results demonstrate the possibility of stimulating the endogenous signaling 
procedures as a regenerative treatment. Although the recent approaches in non-invasive 
stem cell therapies seems to be a promising alternative to invasive technologies, the 
previous achievements in the latter one should not be abandoned. Taking into account 
that the only successful stem cell therapies in humans so far are invasive therapies, they 
still have enormous potential to be a therapeutic approach to such pathological 
conditions  that  lack  clinical  treatments.  One  method  in  therapeutic  treatment  does  not  
exclude another, thus a combination of, for instance, pharmacological non-invasive 
treatment and cell transplantation could be used in order to improve regeneration. To 
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achieve the control over stem cells requires the understanding of them and their 
complex mechanisms of dividing, migrating and differentiating, and the forces that 
drive them to complete this diversity of reactions. 
 
2.3 Identification of the multipotent stem cells 
 
Stem cells expression of neuronal features or ion channels depends on the timing and 
the area of extraction of the cells and the in vitro circumstances they are grown in. This 
makes the question of the existence of these features in an experimental set up 
legitimate. Especially, when studying the effects of a specific ion channel blocker, one 
way of validating the experiment is to indicate the ion channel and the phenotype of the 
cell. 
As described before, the difference between a neuron and a glial cell is not that 
straightforward. Fully understanding the phenotype of maturating neural cells involves a 
range of analyzing methods (Zigova et al, 2002). There are several analytical 
approaches to determine the phenotype of a maturating cell. This chapter introduces 
some of the most commonly used in vitro methods. Methods other than chemical 
labeling and morphology include electrophysiology, northern- and dot blots, in situ 
hybridization, RT-PCR (reverse transcription polymerase chain reaction) techniques and 
pharmacology (Lory et al, 2006), which is reviewed in chapter 4.3. 
 
2.3.1 DNA labeling 
 
Neuroblasts and neurons are unable to divide, while the multipotent glial stem cells 
undergo the continuous cell cycle (Zigova et al, 2002). When the cells divide, they take 
up nucleotides, the building blocks of DNA. A labeled nucleotide, for example a 
tritium-labeled thymidine can be used to separate the dividing cells from neurons. The 
labeled probe is available form minutes to hours after being injected. If a stem cell 
continues to divide, the levels of labeled probe in the cell’s DNA are quickly diluted. If 
a cell undergoes only a single division the neuron retains high levels of labeled DNA. A 
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widely used marker of the newborn cells is 5-bromodeoxyuridine, BrdU. It is a 
halogenated thymidine analog that is permanently integrated into the DNA of dividing 
cells during DNA synthesis in cell cycles S-phase. It indicates the cells that are dividing 
during the period of BrdU exposure. The methods based on DNA labeling are useful 
when the intension is to distinguish the multipotent progenitor cells from differentiated 
cells. 
 
2.3.2 Immunostaining 
 
Immunocytochemical cell identification is an approach to label specific markers that are 
expressed by a certain phenotype (Zigova et al, 2002). Some proteins are specific to 
neurons and some are expressed by different types of glial cells. By immunostainig the 
proteins with antibodies one can detect the morphological and metabolic characteristics 
of the cells and quantify the phenotypes in the assay. The primary antibody attaches to 
the epitope, which is usually a phenotype specific protein on the cell’s surface. The 
secondary  antibody  binds  to  the  primary.  The  secondary  antibody  is  used  to  label  the  
bound primary antibody. In the experiments of this study, fluorescent secondary labels 
have been used. It is also important to examine literature, and choose the relevant 
antibodies and labels. Using more than one primary antibody is necessary for making 
sure that the findings are exactly of the desired phenotype. That is, because of the 
binding is not inevitably specific. Reducing the background staining is also used to 
prevent the non specific binding. That can be done by incubating the cells with serum of 
the species that the secondary antibodies are derived. One more issue to consider is the 
cross-reacting of the antibodies. For example a secondary anti mouse antibody can 
cross-react with a primary mouse antibody, which causes problems in detecting the 
images with microscopy. Here are some examples of antibodies to label a certain kind 
of proteins in the cells. 
An example of a neuronal marker is ?- III tubulin, Tuj-1. It is a neuron specific protein 
that the cells express during their development into mature neurons (Jiang and Oblinger, 
1992). Tubulin isotypes induce axonal growth and the expression of them increases also 
when adult neurons are injured (Hoffman and Cleveland, 1988). 
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To identify glial cells, one can use a phenotype specific protein glial glutamate 
transporter, GLAST (Shibata et al, 1997). It is localized on the cell membrane of mature 
astrocytes and is marker for radial glial cells in the developing brain. 
For identifying calcium channels there is, for instance, a commercially available 
synthetic peptide, which is an antibody produced in rabbit that binds to calcium 
channels ?1 subunit (Westenbroek et al,  1995).  Therefore,  it  binds  to  all  calcium  
currents. 
There are also some T-type specific antibodies on the market that binds to T-type 
calcium channel subunit ?1G. 
 
2.3.3 Morphology 
 
It is difficult to identify developing stem cells by their morphology because it is 
changing constantly during the migration. Yet some characterization is been made and 
the typical morphological features of the cells are well known and agreed. In 1992 
neurons and glial cells were distinguished by their morphology and the results were 
confirmed with  chemical  labels.  The  proliferating  cells  that  expressed  nestin  and  were 
immunoreactive for ?-aminobutyric acid and substance P had a neuronal morphology 
(Reynolds and Weiss, 1992). Also the cells that responded to NSE, neuron specific 
enolase, had small rounded somas with long and fine processes. In contrast, GFAP 
(glial fibrillary acidic protein) immunoreactive cells were stellate, with large somas and 
several thick processes. In the study of Reynold and Weiss the expression of phenotypes 
was restricted. The cells were not immunoreactive for glutamate, serotonin, tyrosine 
hydroxylase, methionine-enkephalin, neuropeptide Y or somatostatin. This is because of 
the other phenotypes appearing at different times or under different culture conditions. 
That is why one cannot expect to find all the possible phenotypes in a one cell culture. 
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2.3.4 Electrophysiology 
 
Electrophysiological methods can be used to explore the functions of ion channels and 
ion  conductances  through  these  channels.  Measuring  the  voltage  of  the  whole  cell  
membrane,  results  in  excessive  background  noise.  To  diminish  that  a  method  of  
measuring a single voltage activated channel was developed and called the patch-clamp 
method (Neher and Sakmann, 1976), as a refinement from its predecessor, voltage-
clamp technique. Nowadays measuring one or multiple channels (whole-cell patch 
clamp) with high resolution is possible (Hamil et al, 1981). Patch clamp recording uses, 
as an electrode, a glass micropipette that has an open tip diameter of about one 
micrometre (Kandel et al, 2000). The tip of the pipette encloses a membrane surface 
area or "patch" that often contains just one or a few ion channel molecules. The interior 
of  the  pipette  is  filled  with  a  solution  matching  the  ionic  composition  of  the  bath  
solution where the cell is, or in some methods, the cytoplasm. A chlorided silver wire is 
placed in contact with this solution and conducts electric current to the amplifier. The 
amplifier is connected to a computer and the software shows the data on the screen. The 
investigator can change the composition of the bath solution or add drugs to study the 
ion channels under different conditions.  
 
 2.4. Migration of stem cells 
 
Migration and differentiation of the cells is controlled not only by genes, but also some 
external and endogenous factors (Emerit and Riad, 1992).  The cells that express certain 
types of transcription factors are determined to differentiate into certain types of cells. 
Regardless, it has been shown in many studies (Kärkkäinen et al, 2009), that there are 
some environmental factors that can regulate the process. Thus, stem cells migration is 
closely related to the modulators of overall neurogenesis, described in the chapter 2.2. 
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2.4.1 Factors that affect migration 
 
To begin their migration, the neural progenitor cells must undergo an essential transition 
from an epithelial to neuronal or glial cell (Hay, 1995). This transformation is induced 
by intrinsic and extrinsic factors. Intrinsic factors are the genes that conduct the changes 
from inside  the  cell.  Extrinsic  factors  include  for  example  growth  factors,  such  as  the  
transforming growth factor ? (TGF-?) which affects the very first transformal changes 
in the cell (Sandford et al, 1997). In addition to morphological changes, other processes 
are required for a cell to start moving away from the epithelium of the spinal tube. 
Disassembling of the cell-cell contacts by expression of adherin molecules and 
reorganization of actin cytoskeleton are the very first changes in the phenotype of the 
cell (Burdsal et al, 1993; Hay, 1995). The cells must downregulate expression of 
adhesive genes so that they can move and migrate freely. Other factors associated with 
cell detachment are proteins reelin, tenascin-R and prokineticin 2 (Hack et al, 2002; 
Saghatelyan et al, 2004; Nguyen et al, 2001). 
 As essential as the detachment from other cells is to a single cell, it is equally important 
to the cell to attach to its environment. One change in extracellular matrix proteins is the 
expression of integrins. Especially alphaV integrin seems to be important for migration 
since interfering with its function inhibits migration in cell cultures (Blaschuk et al, 
2000). These provide appropriate levels of adhesion to promote cell motility. 
Extracellular matrix proteins known to interact with integrins are chondroitin sulphate, 
tenascin-C, laminin and proteoglycans (Thomas et al, 1996). 
Several growth factors regulate migration. Platelet-derived growth factor (PDGF) and 
epidermal growth factor (EGF) keep the cells in migratory and immature state (Assanah 
et al, 2006; Ivkovic et al, 2008). In addition, PDGF seems to have chemoattractive 
features, as the cells migrate towards higher concentrations of PDGF in a transfilter 
migration assay (Armstrong et al, 1990). Neural growth factors BDNF and GDNF are 
also considered as chemoattractants in what comes to their roles in migration (Paratcha 
et al, 2006; Chiaramello et al, 2007). Many agents that serve some other purpose have a 
chemoattractive nature. A pure chemoattractive compound is a chemokine, SDF-1 
(Imitola et al, 2004). 
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Polysialylated NCAM (PSA-NCAM) that belongs to the immunoglobulin superfamily 
and doublecortin (DCX) which is a microtubule-associated protein facilitate the 
translocation of the cell in migration (Ono et al, 1994). Translocation is a term 
describing the cells movement. 
There are a number other factors that control not only the migration, but other stages of 
neurogenesis, proliferation and differentiation. These mentioned factors are not limited 
to migration. These phases are sometimes difficult to separate because they occur partly 
at the same time in an overlapping manner, and a certain factor clearly connected to 
migration or some other developmental period is not that evident. 
 
2.4.2 Physical movement of the cells 
 
The morphological changes in neuroepithelial cells were already described in 1977 by 
Domesick and Morest. The cell body moves forward within a leading process 
(Domesick and Morest, 1977). A variety of patterns occur in this movement within the 
cells. There are differences in speed and in the manner of moving either constantly 
forward  or  in  a  saltatory  way.  The  latter  manner  is  intermittent  moving  in  bursts  with  
little or no movement between the bursts. 
Two main migration modes are described during development: radial and tangential 
migration (de Carlos et al, 1996; Anderson et al, 2001). Radial glial cells of the 
ventricular zone (VZ) provide tracks along which immature neurons migrate into the 
cortex. This type of migration is called radial migration because the cells migrate 
perpendicular to the ventricular surface. Neuronal progenitors born in the SVZ migrate 
in a characterized tangential migration forming chains towards the olfactory bulb. 
Newborn neurons integrate into the pre-existing neuronal network and traverse along 
the chains made by radial glial (RG) cells. This three-dimensional movement causes 
problems in two-dimensional in vitro-  circumstances.  In  the  growth  medium cells  can  
grow in a limited amount of layers.  
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2.4.3 Migration in pathological conditions 
 
Cell proliferation and migration are almost always disturbed in a diseased brain (Cayre 
et al, 2009). Developmental cell migration disruption causes neurological disorders, not 
only in developing, but also in the adult brain. Disruptions in the migration can lead to 
many psychiatric disorders: autism, retardation, schizophrenia, epilepsy and 
neurodegenerative diseases. The role of neurogenesis in chronic neurodegenerations is 
rather uncertain. In Alzheimer’s disease the hippocampal neurogenesis is increased (Jin 
et al, 2004). This happens supposedly because the newborn neurons replace the dead 
ones. Conversely, dopamine depletion impairs precursor cell proliferation in Parkinson 
disease (Höglinger et al, 2004). This seems logic according to the fact that dopamine 
positively regulates adult neurogenesis (Baker et al, 2004). Research in epilepsy affords 
contradictory findings. Dentate gyrus neurogenesis is stimulated by pilocarpin-induced 
seizures (Parent et al, 1997; Gong et al, 2007). Recent work challenges these results 
performed on hippocampal biopsies of patients with temporally lobe epilepsy. This 
study suggests that epileptic activity does not stimulate neurogenesis in the human 
dentate gyrus (Fahrner et al, 2007). 
In the case of ischemia and acute injury the role of progenitor cell activity and migration 
is  clearer.  Similar  observations  are  made  in  a  variety  of  studies  (Miles  and  Kernie  
2006). In rodent models ischemia leads to proliferation of dentate gyrus progenitors 
together with migration towards the injured area (Liu et al, 1998). 
In schizophrenia, hippocampal stem cell proliferation is impaired in patients (Reif et al, 
2006) as well as in animal models (Liu et al, 2006). Several molecules that play crucial 
roles in cell migration are disrupted in schizophrenia patients (Stefansson et al, 2003). 
One of them is Reelin that takes part to cell detachment (Hack et al,  2005).  Also  a  
chemoattractant protein NRG1 (neuregulin-1) and its receptor Erb4 are disrupted 
(Steffanson et al, 2003). 
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2.4.4 The role of voltage gated ion channels in neurogenesis 
 
Researchers Hitoshi Komuro and Pasko Racik have made a lot work studying the role 
of calcium fluctuations and calcium ion channels in neurogenesis. In 1992 they reported 
that the rate of granule cell movement depends on both extracellular calcium 
concentrations and calcium influx through N-type calcium channel (Komuro and Rakic, 
1998). They have proven the movement inducing effect of intracellular calcium 
fluctuations in many studies (Komuro and Rakic, 1992; 1993; Rakic and Komuro, 1995; 
1996; 1998). These findings were gained with newborn progenitor cells starting their 
migration and differentiation. N-type calcium channel seemed to have a specific effect 
on migrating cells (Komuro and Rakic, 1998). A statistically significant decrease in the 
rate  of  migration  was  gained  with  a  30  nM  concentration  of  a  specific  N-type  
antagonist, omega-conotoxin, ?-CgTx. This concentration of toxin decreased the rate by 
24 %. The effect was dose-dependent, lowering the rate by 50 % at 300 nM of ?-
conotoxin, 65 % at 1000 nM and >78 % at 3000 nM. They also studied the effect of L- 
and T-type calcium channels and reported no significant effect. A T-type channel 
blocker nickel was used at 100 µM and to block L-type channels they used a specific 
blocker nifedipine at a concentration of 5 µM. Also Na+-channels were blocked with its 
specific antagonist tetrodotoxin at the concentration of 10 µM and with no significant 
effect. 
Another study reports a response to L-type calcium channel antagonist nifedipine in 
olfactory bulb progenitor cells. Compared to the studies of Komuro and Rakic, these 
data were gained from cells after three days growing in vitro (Cigola et al, 1998). A 
significant change in the cells phenotype and their expression of ion channels happens 
during the very first days of differentiation (Kärkkäinen et al, 2009). In the study of 
Cigola et al., after one day of differentiation a small population of immunostained 
neurons was detected (Cigola et al, 1998). After additional two days the number had 
doubled. The study demonstrated that L-type calcium channels mediate the regulation 
of the dopamine phenotype of neurons.  
Another study presents similar findings. In neural progenitor cells derived from 
postnatal mice cortex, stimulation of L-type calcium channel with its specific agonist 
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BAY K 8644, induced the neuronal differentiation significantly (D’Ascenzo et al, 
2006). Treatment with an antagonist nifedipine at 5 µM produced opposite effects. 
These  experiments  were  made  with  cells  after  12  days  growing  in vitro.  All  this  data  
shows that calcium has a significant role in progenitor cells development, in migration 
and differentiation. The role of T-type calcium channel is discussed in chapter 3.2. 
 
 
3. Classification of voltage activated calcium channels 
 
A ligand, which is a receptor binding molecule, regulates transmembrane ion channels 
(Koulu and Tuomisto, 2007). Some endogenous ligands are acetylcholine, GABA, 
glysine and glutamate. In addition to these ligand activated channels, there are voltage 
activated ion channels. Conversely to ligand activated channels, voltage gated ion 
channels do not function as receptors for physiological transmitters. Instead, there are 
many pharmacological substances that can bind also to voltage gated ion channels. Such 
compounds are for instance, calcium blockers that are used to treat hypertension, 
majority of anti-arrhythmic agents and beta-blockers.  
Calsium ion is a common intra- and extracellular messenger, which takes part to 
neurotransmission and actionpotential. Over the past years the voltage-gated calcium 
channels have gained attention, due to their role as activators of gene expression and 
cell fate by regulating the downstream signaling to the nucleus (Spitzer et al, 1994). 
Voltage-gated calcium channels are known to mediate calcium influx in response to 
membrane depolarization (Yu et al, 2005). They also regulate intracellular processes 
such as contraction, secretion and neurotransmission in many different cell types. They 
belong to a gene superfamily of transmember ion channel proteins that includes voltage-
gated potassium and sodium channels. 
The voltage-gated calcium channels can be divided into two groups, low-voltage 
activated (LVA) and high-voltage activated (HVA) channels (Koulu and Tuomisto, 
2007). HVA -channels consist of L-type channels situated mostly in the cardium, as 
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well  as  P/Q,  N  and  R-  type  channels.  The  LVA-  channels  are  also  known  as  T-type  
calcium channels. All these channel types can be further divided into ?1- subunits. 
 
 
Table 1 Classification of voltage-activated calcium channels 
 
 
 
There are altogether ten members of the voltage-gated calcium channel family 
(Catterall, 2005). Calcium currents have diverse physiological and pharmacological 
properties, distribution in different cell types and therefore they stand for distinct classes 
named among an alphabetical nomenclature (Tsien et al, 1988). High-voltage activated 
channels L, N, P/Q and R require strong depolarization for activation, whereas the low-
voltage activated T-type currents are activated by weak depolarization and are transient. 
The rational nomenclature, based on the well defined potassium channel nomenclature 
was created in 1997 (Ertel et al,  1997).  The  name of  calcium channels,  Ca,  stands  for  
the chemical symbol of the principal permeating ion, calcium, with the principal 
physiological regulator (voltage) indicated as a subscript (Cav). The numerical identifier 
corresponds to the ?1 subunit gene subfamily (1 to 3, see table x). 
Dividing channels into subtypes is based on the ?1 subunit, which is the largest subunit 
of the calcium ion channel (Hofmann et al, 1994). It consists of four homologous 
domains with six transmembrane segments. Encoded by multiple genes, the ?1 subunits 
differ by pharmacological and electrophysiological activities. The complete amino acid 
L-type
•CaV1.1 (?1s)
•CaV1.2 (?1c)
•CaV1.3 (?1d)
•CaV1.4 (?1F)
P/Q-type 
•CaV2.1 (?1A)
N-type
•CaV2.2 (?1B)
R-type
•CaV2.3 (?1E)
T-type
•CaV3.1 (?1G)
•CaV3.2 (?1H)
•CaV3.3 (?1I)
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sequences of these ?1 subunits are more than 70 % identical within a subfamily but less 
than 40 % identical among the three subfamilies. 
 
3.1 High-voltage activated calcium channels 
 
L-type calcium channels are localized mainly in vascular endothelial cells and in the 
heart (Koulu and Tuomisto, 2007). Specific antagonists for these channels are 
dihydropyridines, phenylalkylamines and benzothiazepines (Hockerman et al, 1997). In 
muscle and endocrine cells the L-type calcium channels are the main calcium currents. 
Their function in those tissues is to initiate contraction and secretion. Dihydropyridines 
are commonly used to treat hypertension by blocking L-type channels in the 
myocardium and vascular endothelium. Their main effect in vivo is vasodilatation 
(Koulu and Tuomisto, 2007). Other physiological functions that L-type channels take 
part in are hormone release, regulation of transcription, synaptic regulation, hearing and 
neurotransmitter release from sensory cells (Hockerman et al, 1997). CaV1.4 channel 
subtype’s specific function is to release neurotransmitters from photoreceptors. 
Both P/Q- and N-type calcium currents are distributed in nerve terminals and dendrites, 
as well as in neuroendocrine cells (Catterall et al, 2005). In these cells they are involved 
in neurotransmission at most fast synapses and mediate calcium entry into cell bodies 
and dendrites. This CaV2 subfamily of calcium channels is relatively insensitive to 
dihydropyridines, but these channels are specifically blocked with high affinity by 
peptide toxins from spiders and marine snails (Miljanich and Ramachandran, 1995). 
The CaV2.1 channels are blocked specifically by ?-agatoxin from funnel web spider 
venom.  A  specific  blocker  of  CaV2.2 channels is ?-conotoxin, which is a snail toxin. 
The CaV2.3 channels are antagonized by a synthetic peptide toxin SNX-482 which is 
derived from tarantula venom. 
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3.2 Low-voltage activated calcium channels 
 
The T-type calcium currents, CaV3 channels, are insensitive to both dihydropyridines 
and  the  spider  and  snail  toxins  that  block  HVA  channels.  There  are  no  widely  useful  
pharmacological agents that block T-type calcium currents (Perez-Reyes, 2003). There 
are somewhat selective antagonists for T-type channel. One of them is mibefradil which 
is 3- to 5-fold more selective to T-type than L-type calcium currents. A peptide toxin 
kurtoxin inhibits the activation gating of CaV3.1 and CaV3.2 channels. Such a chemical 
agent that is more specific and binds to T-type calcium channels with high-affinity 
would be beneficial for therapy and more detailed analysis of the physiological roles of 
these channels (Catterall et al, 2005). 
 
 
4. T-type calcium channels 
 
4.1 T-type calcium channels electrophysiology 
 
The  T-type  calcium channel  family  consists  of  three  alpha  subunits,  ?1G, ?1H, and ?1I 
(Fox et al, 1987). These low voltage activated channels, LVAs, can activate at 
significantly lower activating potentials than the high voltage activated channels. Under 
physiological recording conditions, the apparent activation threshold for IT is near 
resting membrane potential -50 mV to -60 mV (Huguenard and Prince, 1992; Umemiya 
and Berger, 1994). High threshold calcium channels require activating potentials more 
positive than -40 mV to open (Sundgren-Andersson and Johansson, 1998). In CNS 
neurons,  the  resting  potential  is  lower  than  –  60  mV.  Several  studies  have  been  made  
using isolated neurons from a variety of brain regions (White et al, 1989; Allen et al, 
1993; Kuo and Yang, 2001). In these studies the membrane potential was measured by 
holding the cell at – 90 mV and then increasing depolarizing pulses in -10 mV 
increments.  T-type channels begun to activate when the membrane potential 
depolarized above -60 mV, while the HVA currents peaked around 0 mV. T-type 
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currents also depolarized and decayed slowly, the whole action potential lasting for 
hundreds of milliseconds. In contrast, the HVA channels activate fast and recovery in 
relation to activation is slow. Another specific function of LVA currents in neuronal 
excitability is that they mediate low-threshold burst discharges throughout the brain.  
Low-threshold calcium spikes, LTS, have been described in slices and in isolated 
neurons  from  several  parts  of  the  brain  (see  for  review,  Perez-Reyes  E,  2003).  These  
bursts or spikes appear under physiological and pathological conditions. LTS cannot be 
triggered by depolarization from the resting membrane potential, which is typically 
between  -60  and  -65  mV  (Kim  et al, 2001). These spikes occur during the 
hyperpolarization. LTS begun to appear after the neuronal cells membrane was 
hyperpolarized below -69 mV and full-amplitude spikes were observed when the 
membrane  potential  reached  -73  mV.  As  a  conclusion,  the  role  of  these  spikes  is  
considered  as  a  pacemaker.  LTS  can  trigger  a  burst  of  action  potentials  that  are  brief  
and happen in high frequency, especially in some thalamic neurons (Sundgren-
Andersson and Johansson, 1998). This can also be called burst firing. T-type calcium 
channels play a role in neuronal rhythmogenesis also referred to as oscillations, such as 
the sleep-related slow electroencephalographic (EEG) waves, rhythms related to motor 
coordination, learning and hyper-synchronous oscillations during epilepsy (Huguenard, 
1996). 
 
4.2 T-type calcium channels functions 
 
Although being expressed throughout the body, T-type calcium channels are widely 
expressed in the nervous system, and sometimes at very high densities (Talley et al, 
1999). In CNS, T-type channel’s have a very specific role in neuronal rhythmogenesis 
(Huguenard, 1996). T-type channel’s peripheral functions include taking part in muscle 
contraction, hormone secretion and pain (Perez-Reyes, 2003). This thesis concentrates 
on the most documented CNS functions of T-type calcium channel. Neuronal 
rhythmogenesis, operated by T-type channel, include sleep-related EEG waves, rhythms 
related to motor coordination, learning, memory and epilepsy, in addition to sensory 
transmission, dendritic integration, neurotransmitter release and neural development 
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(Cueni et al, 2009). From the viewpoint of this study it is interesting to note some 
similarities in what comes to all of these functions. There is a connection between sleep, 
brain development and learning. How is T-type calcium channel related to the forming 
of synaptic connections? Does the malfunction of this channel manifest in a form of 
absence epilepsy? Some answers can be found in the literature and the conclusions that 
can be made according to it. 
 
4.2.1 Electric oscillations during the sleep 
  
Sleep in mammals comprises two distinct states, REM (rapid eye movement) and 
nonREM (NREM) sleep, which alternate at fairly regular intervals throughout each 
sleep period (Carskadon and Dement, 2000). During a natural night sleep the EEG 
activity of the brain is characterized by regular oscillations at different frequencies 
(Horne, 1988; Niedermeyer and Lopes da Silva, 1993). These EEG waves can be 
divided into groups by their frequencies. The so-called beta (10–20 Hz) and gamma 
(20–80 Hz) waves are detected when a person is awake and in a fully attentive state. 
Relaxed wakefulness is characterized by alpha (8-13 Hz) waves and NREM sleep by 
theta (3-7 Hz) waves. As the sleep deepens, the oscillations slow down to frequencies of 
delta waves (1-4 Hz) and deeper delta waves (< 1 Hz). 
 
The rhythmic action potential bursts underlying alpha/theta waves have been named 
high threshold bursts, HTBs.  These are made by thalamo-cortical, TC neurons that fire 
repetitive, relatively short bursts of action potentials in synchrony with EEG waves at 
these frequencies (Hughes et al, 2004). Logically, original observations suggested that 
HTBs were mediated by high threshold calcium channels (Hernandez-Cruz and Pape, 
1989; Jahnsen and Llinas, 1984). However, the spikes that underlie HTBs are more 
effectively blocked by relatively small concentrations of Ni2+ than Cd2+ (Hughes et al, 
2004).  Nickel  ion  is  a  relatively  specific  antagonist  of  T-type  calcium  currents  (Biagi  
and Enyeart, 1991). This observation led to a conclusion of T-type channels being more 
involved in TC neurons high threshold bursts (Hughes et al, 2004). Similar activity of 
HTBs that involve a contribution by T-channels have been shown in many other 
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neuronal types including hippocampal CA1 pyramidal neurons (Magee and Carruth, 
1999), cortical (Gibson et al, 1999) and thalamic interneurons (Zhu et al, 1999) and 
NRT neurons (Landisman et al, 2002). Since HTBs are also moderately suppressed by 
nifedipine, it is unlikely that T-channels are solely responsible for their generation 
(Hughes et al, 2004). 
 
The slow sleep rhythm (< 1 Hz) is present in almost all stages of NREM sleep, underlies 
the sleep K-complex and groups together periods of delta waves (Amzica and Steriade, 
1997)  and  sleep  spindles  (Amzica  and  Steriade,  2002).  The  K-complexes  are  an  EEG  
manifestation of repeatedly varying membrane potentials from depolarization to 
hyperpolarization, called as UP and DOWN states respectively. The membrane 
potentials switching from depolarization to hyperpolarization and back are mediated by 
ITwindow in TC and NRT (nucleus reticularis) neurons (Crunelli et al, 2005). The writers 
named the combination of recombinant T-type Ca2+ channels  (Cav3.1, Cav3.2 and 
Cav3.3) as ITwindow. 
 
Sleep spindles are a burst of EEG waves, that occur during the stages 2 and 3 of natural 
NREM sleep in humans, has a frequency of 12-15 Hz, lasts for a few seconds and has a 
feature of increasing and waning waveform (Niedermeyer and Lopes da Silva, 1993). 
Since the low threshold calcium potentials, LTCPs, are present at almost every cycle of 
the spindle wave in TC and NRT neurons,  the role of T-type channels is  quite evident 
(Steriade et al, 1985; von Krosigk et al, 1993; Contreras and Steriade, 1996). 
 
To summarize, the T-type channels constitute the single, most crucial voltage-
dependent conductance that permeates all major non-REM sleep oscillations in 
thalamocortical and NRT neurons, including oscillations that stand for theta waves, K-
complex,  slow  sleep  rhythm,  sleep  spindles  and  delta  waves.  In  the  light  of  current  
views on the critical function of NREM sleep in learning and memory (Bennington et 
al, 2003), one could expect that T-type channel has also some other patho-physiological 
significance. 
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4.2.2 Memory and learning 
 
The dominant model of activity-dependent synaptic plasticity was represented already 
in 1949 as the Hebbian synapse when Hebb presented his finding of neural networks 
having learning-related properties (Hebb, 1949). His theory was that synaptic activity 
enhances learning, if the synaptic inputs that activate the postsynaptic neurons are 
strengthened. On the other hand, some other postsynaptic neurons need to be silent. In 
other words, neuronal transmission strengthens the synapse. The experimental methods 
of learning are based on this theory. There are several studies that have investigated the 
relevance of cellular phenomenons to learning, by genetic or pharmacological 
manipulations that affect LTP (long-term potentiation) and LTD (long-term depression) 
in learning abilities in experimental animals (e.g. Miller and Mayford, 1999; Yin and 
Tully, 1996). The outcome of these studies has been that stimulation of neurons leads to 
nuclear transcription and protein synthesis in neuronal networks. The stimulation does 
not always necessarily lead to long-term potentiation, but can also trigger LTD, long-
term depression, which leads to decay or silencing of synaptic interactions. The 
necessary condition for inducing LTD is activation of a specific synapse without action 
potential in the postsynaptic neuron (Kemp and Bashir, 2001). 
 
It has been suggested, that REM sleep could influence synaptic plasticity producing 
LTP (Aston-Jones and Bloom, 1981). However, the neuronal activity during REM sleep 
is substantially similar to that of being awake (Hobson and Steriade, 1986). This 
questions the specific role of REM sleep in neuronal plasticity. The main difference 
between REM sleep and wakefulness is the dramatic decrease in release of 
norepinephrine and serotonin in REM sleep.  Reduced norepinephrine release could 
stand for LTP, but does not explain it thoroughly (Bramham and Srebro, 1989). 
Synaptic plasticity has also been related to NREM sleep being a homeostatic regulator 
due to the minimal neurotransmission happening in it (Benington, 2000). 
 
Putting the question in other order has resulted with more clear effects. Instead of 
asking “Does the sleep enhance synaptic plasticity?” The question can be posed as 
“Does sleep-deprivation impair learning and synaptic plasticity?” Sleep deprivation 
does profoundly interfere with learning and memory in mice and rats, especially in 
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demanding tasks that presumably require more complex cognitive processing (Block et 
al, 1981; Smith, 1985, 1995). A range of studies suggest the same causes of sleep 
deprivation. Since the neuronal activities of NREM sleep are produced largely by two 
types of ion channels: the T-type calcium channel and a hyperpolarization activated 
cation channel (Ih) (Steriade et al., 1993b), one might conclude that T-type has a role in 
synaptic plasticity and thus in learning and memory. 
 
In mature CA1 hippocampal pyramidal cells, a contribution of T-type channels to 
NMDA-receptor –dependent long-term potentiation was reported (Thomas et al, 1998). 
Another study reported that increase in postsynaptic calcium concentration, resulting 
from subthreshold excitatory synaptic activity in cerebellar Purkinje neurons, led to 
synaptic integration (Eilers et al, 1995). Before that it was thought, that synaptic 
integration results from the simple summation of electrical signals produced by each 
active synapse innervating a given neuron. The finding of some non-electrical, 
subthreshold synaptic integration caused by a second-messenger, calcium, occurs, 
revealed another function of low-threshold calcium channels. One form of cerebellar 
LTP is parallel-fibre (PF)- Purkinje cell stimulation (Lev-Ram et al, 2002). T-type 
calcium channels are the main component of the LVA calcium input in dendritic spines 
(Isope and Murphy, 2005). 
 
Surprisingly, PF-long term depression still provides the most convincing example 
available showing that alterations in synaptic strength can mediate behavioral learning 
(Jörntell and Hansel, 2006). The creation of new synaptic connections requires the 
decay of older ones, with a complexity of mechanisms fortifying and silencing synaptic 
interactions. Other studies yet indicate that both LTP and LTD are the main 
mechanisms of synaptic plasticity (Bliss and Collingridge, 1993; Bear and Malenka, 
1994). Both of these activities are dependent on Ca2+ entry through NMDA receptors 
(Bear and Malenka, 1994). The increases in Ca2+ associated with LTD are both smaller 
and longer lasting than those associated with LTP (Cho et al, 2001; Cornier et al, 2001). 
Since the critical difference between LTP and LTD is indeed that smaller increases in 
Ca2+ produce LTD, the involvement of T-type Ca2+ channels in LTD is reasonable 
(Benington and Frank, 2003). A range of other studies show that T-type calsium 
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channels have been implicated in long-term depression, LTD, induced by metabotropic 
glutamate receptors (mGluRs) (Oliet et al, 1997; Birtoli and Ulrich, 2004; Bender et al, 
2006; Nevian and Sakmann, 2006). As both LTD and LTP are uniquely important for 
neuronal plasticity, the hebbian thesis still seems to apply. 
 
4.2.3 Epilepsy 
 
Absence seizures in epilepsy are characterized by a brief loss of consciousness 
associated with an EEG recording of 3 Hz bilaterally synchronous spike-and-wave 
discharges (SWDs) (Niedermeyer, 1996; Williams, 1953). These discharges are burst-
like action potentials, the so-called burst firing, in thalamo-cortical neurons, TC 
neurons (Crunelli and Leresche, 1991). This characteristic firing pattern of TC neurons 
is evoked by low-threshold Ca2+ potentials (LTCPs) (Deschénes et al, 1984; Jahnsen 
and Llinás, 1984). Therefore, it has been proposed, that low-threshold T-type calcium 
channels are involved in the genesis of absence seizures in the thalamocortical network 
(Coulter et al, 1989; Crunelli and Leresche, 1991). More evidence of T-type channels 
dysfunction in absence epilepsy is gained in studies with genetically modified animals. 
T-type calcium channels were moderately increased in the thalamic neurons of the 
genetic absence epilepsy rat from Strasbourg (GAERS), a model of spontaneous 
absence epilepsy (Tsakiridou et al, 1995). In addition, one group generated knockout 
mice for the ?1G subunit of the T-type channel. It revealed, that the mice lacked burst 
firing in thalamocortical relay neurons, and thereby were resistant to absence seizures, 
that were caused by systemically injected ?-butyrolactone or (RS)-baclofen. Absence 
seizures induced by systemic injecting of these drugs were demonstrated before (Snead 
et al, 2000). These findings have supported development of a specific T-type antagonist, 
ethosuximide (Coulter et al, 1989; Kostyuk et al, 1992). 
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5. T-type calcium channel’s role in neurogenesis 
 
The question of T-type calcium channel’s actual role in neurogenesis remains yet 
unanswered. However, a few studies have led the researchers closer to finding an 
answer. The role of Ca2+ being a key regulator in the process of neural induction is well 
established (Webb et al, 2005). In spite of that, there is a gap in our knowledge, in what 
comes to the exact functions of each calcium channel subtype during the neurogenesis. 
During the neurogenesis, T-type calcium channels appear first, are widely expressed, 
until later the HVA calcium currents appear by the maturating of neurons (Yaari et al, 
1987). After this takes place, the ratio starts changing constantly towards a dominating 
population of HVA currents. In vitro this effect is more marked at differentiation days 
3 to 5 (D3-D5) (D’Ascenzo et al, 2006). 
 
It has been shown, that T-type calcium channel ?1H participates in the morphological 
and electrical differentiation of neuroblastoma (tumor-cells) NG108-15 cells (Chemin 
et al, 2002; 2004). Pharmacological inhibition of T-channel activity impairs HVA 
channel expression and neuritogenesis, i.e. maturation of neurons, indicating that T-
type channels have a crucial role in both morphological and electrical changes during 
the early stage of neuronal differentiation (Chemin et al, 2002). Treatment with the T-
channel blockers Ni2+ and mibefradil significantly decreased the number of cells with 
neurites. Percentage of cells with neurites was 65 % of the number in control cells 
when treated with Ni2+, and 78 % when treated with mibefradil, whereas HVA blockers 
had no effect. Authors concluded that T-type calcium channels trigger the onset of 
differentiation  and  regulate  the  expression  of  HVA  channels.  Soon  after  birth,  the  
expression of T-type channels collapses in visual cortex and hippocampal neurons and 
early action potential possibly depends on T-type channels (Nowycky et al, 1985). This 
early development of T-type channels is widely reported. In embryonic Xenopus young 
spinal neurons T-type channels are present during the calcium-sensitive period (Gu and 
Spitzer, 1993). Later on, they disappear, and in mature neurons only half of them 
express T-type calcium channels, in contrast to HVA current, which persists in all 
neurons. The same developmental change occurs also in other embryonic systems, 
including rat hippocampal neurons, chick dorsal root ganglion cells and ciliary 
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ganglion neurons, chick motoneurons, rat hippocampal pyramidal neurons, and neurons 
of the rat neostriatum. Gu and Spitzer conclude that the early appearance of T-type 
calcium channel in different embryonic cells suggests that it may play an important role 
in their development. T-type channel’s function in mature neurons is better known than 
its role in neurogenesis. It appears that they trigger activation of HVA currents in 
young neurons and lower the threshold of action potentials (Gu and Spitzer, 1993). 
Interestingly, T-current has no effect on the threshold of mature neurons.     
 
Conducting neurogenesis into neuritogenesis is controlled by HVA channels, especially 
by L-type calcium channels, and it plays a key role in promoting neuronal 
differentiation (D’Ascenzo et al, 2006). Ca2+ influx through Cav1 current promotes 
neuronal differentiation, which was reduced by 77 % compared to control cells, after 
blocking  the  channel  with  5  µM  nifedipine.  In  contrast,  treatment  with  an  L-channel  
activator BAY K 8644 significantly increased the percentage of cells expressing 
neuronal markers. Also increasing free internal calcium with 100 nM ionomycin, leads 
to increased neuritogenesis by 15 % compared to the control cells (Chemin et al, 2002). 
 
It is claimed that T-type calcium channels contribute to the secretion of autocrine 
differentiation factor(s) that promote neuritogenesis (Chemin et al, 2003). This self-
regulating system appears also as a positive feedback loop, as the enhancement of 
calcium channel’s activity during differentiation produces increases in Ca2+ influx, 
which in turn appears to promote further neuronal differentiation (D’Ascenzo et al, 
2006). Authors of this study suggest that their findings of the calcium playing a pivotal 
role in NSC differentiation raise possibilities for pharmacologic enhancement of the 
neurogenic potential of NSCs in situ. This means that modulation of Ca2+ influx might 
be a useful tool to increase differentiation toward the neuronal lineage when NSCs are 
manipulated and expanded in vitro prior to transplant in vivo. 
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6. T-type calcium channel subtypes 
 
6.1 CaV3.1 channel subtype 
 
Between T-type calcium channels, there are differences and similarities in their 
biophysical properties (Klöckner et al, 1999). CaV3.1 channel subtype, also marked as 
?1G subunit, shows the fastest activation and inactivation kinetics. It activates at -46 
mV in 1 millisecond and inactivates at -73 mV in 11 ms. 
 
?1G subunit has no known activators nor radioligands. Instead, there are some 
antagonists known to block the channel, although no subtype-specific blocker exists 
(Heady et al, 2001). Overall T-type channel antagonists as mibefradil (Martin et al, 
2000), U92032 (Avery and Johnston, 1997), penfluridol and pimozide (Santi et al, 
2002), amiloride (Lacinova et al, 2000), ethosuximide (Gomora et al, 2001) and nickel 
(Lee et al, 1999) antagonize also this channel subtype. A gating modifier, peptide toxin 
named kurtoxin, affects this channel (Chuang et al, 1998). 
 
CaV3.1 channel subtype is widely expressed over the brain. It is distributed especially to 
soma and dendrites of neurons in olfactory bulb, amygdala, cerebral cortex, 
hippocampus, thalamus, hypothalamus, cerebellum and brain stem (Perez-Reyes et al, 
1998). Peripherally this channel subtype is expressed in ovaries, placenta and heart 
(Catterall et al, 2005). The interesting point in channel distribution is that it is closely 
related to the channel subtypes’ physiological functions. In the case of ?1G subunit, its 
main physiological function in producing thalamic oscillations, correlate with its 
expression in the thalamic areas (Perez-Reyes, 2003). 
 
6.2 CaV3.2 channel subtype 
 
T-type calcium channel subunit CaV3.2, or ?1H, has the second lowest activation and 
inactivation kinetics of the three T-type calcium channel subtypes. It activates at -46 
mV in 2 milliseconds and inactivates at -72 mV in 16 ms (Klöckner et al, 1999). 
36 
 
 
CaV3.2 subtype has no known activators, nor radioligands, but instead there are many 
substances that antagonize it (Catterall et al, 2005). It is significantly more sensitive to 
the  block  of  nickel  than  CaV3.1 and CaV3.3 subtypes (Lee et al, 1999). ?1H subunit is 
antagonized also by the other overall T-type channel antagonists, mibefradil, U92032, 
penfluridol and pimozide, ethosuximide and amiloride. In addition, it is sensitive to 
nonselective antagonists, nimodipine (Williams et al, 1999) and some anesthetics (Lee 
et al, 1999). Kurtoxin is a gating modifier of this channel as well as the CaV3.1 channel 
(Chuang et al, 1998). 
 
This channel subtype is expressed in several brain areas, especially in olfactory bulb, 
striatum, cerebral cortex, hippocampus and reticular thalamic nucleus (Talley et al, 
1999). CaV3.2 channel takes part in thalamortical dysrhythmias, which are related to the 
pathology of absence epilepsy (Llinas et al, 1999). It is widely expressed also in 
peripheral tissues including kidney, smooth muscle, liver, adrenal cortex and heart. Its 
peripheral physiological actions go together with these findings. They are smooth 
muscle contraction, smooth muscle proliferation, aldosterone secretion and cortisol 
secretion (Catterall et al, 2005). It looks like this calcium channel subtype has more 
important peripheral functions than CNS functions. T-type calcium channels have also 
been suggested to be potential drug targets in hypertension and angina pectoris, due to 
their cardiac and vascular functions, which are quite similar to those of L-type calcium 
channels (Ertel et al, 1997). This effect is probably mostly due to the CaV3.2 channel 
subtype. 
 
6.3 CaV3.3 channel subtype 
 
Calsium channel subtype CaV3.3, or ?1I subtype, has the slowest activation and 
inactivation kinetics of the three T-type calcium channel subtypes. It activates at -44 
mV in 7 milliseconds and inactivates at -72 mV in 69 ms (Klöckner et al, 1999). The 
activation and inactivation potentials are very similar among the three channel subtypes. 
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Similarly to other T-type channel subtypes, it has no known activators or radioligands 
(Catterall et al, 2005). ?1I channel has no subtype-specific blocker (Heady et al, 2001), 
but it is antagonized by the same compounds as CaV3.1 and CaV3.2, mibefradil, 
U92032, penfluridol, pimozide, ethosuximide and nickel. Kurtoxin does not affect this 
channel subtype, in contrast to the other two subtypes (Chuang et al, 1998). 
 
?1I subunit is distributed to brain, especially olfactory bulb, striatum, cerebral cortex, 
hippocampus, reticular nucleus, lateral habenula and cerebellum (Talley et al, 1999), 
and its main function is causing thalamic oscillations (Perez-Reyes, 2003). It does not 
seem to have any significant peripheral roles and it is mostly expressed in CNS. For a 
summary of all the T-type calcium channel subtypes, see Table 2.  
38 
 
Channel 
subtype 
Blockers Activators Gating 
modifiers 
Distribution Physiological 
functions 
Special 
features 
 
 
 
CaV3.1 mibefradil, 
U92032, 
penfluoridol, 
pimozide, 
nickel, 
amiloride 
not 
established 
kurtoxin CNS, ovary, 
placenta, 
heart 
thalamic 
oscillations 
kurtoxin 
has a high 
affinity to 
this 
channel: 
IC50 = 
15nM 
CaV3.2 mibefradil, 
amiloride, 
U92032, 
penfluridol, 
pimozide, 
nickel 
(nimodipine 
and 
anesthetics)  
not 
established 
kurtoxin CNS, 
kidney, 
liver, 
adrenal 
cortex, heart 
smooth 
muscle 
contraction 
and 
proliferation,  
aldosterone 
and cortisol 
secretion 
nickel is 
the most 
selective 
blocker of 
this 
channel: 
IC50 = 
12µM 
CaV3.3 mibefradil, 
U92032, 
penfluridol, 
pimozide, 
nickel 
not 
established 
none CNS thalamic 
oscillations 
distribution 
mainly in 
CNS 
Table 2, T-type calcium channel subtypes characters 
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7. Pharmacology of T-type calcium currents 
 
Pharmacological substances have been important in the identification of voltage-gated 
Ca2+-channels (Tsien et al, 1988; Olivera et al, 1994; Randall and Tsien, 1995; Mishra 
and Hermsmeyer, 1994). Compounds showing specificity towards T-type calcium 
channels include drugs from diverse therapeutic groups such as antihypertensives, 
antiepileptics, antipsychotics and anesthetics (Perez-Reyes, 2003). In addition to 
therapeutic compounds, there are some T-type-specific di- and trivalent cations and 
peptide toxins for the use of physiological experiments. 
In  this  study,  the  action  of  T-type  channels  is  detected  as  the  cells  response  to  some  
known T-type calcium channel antagonists. Therefore, to validate the method, it is 
crucial  to  find  out  the  other  actions  of  these  antagonists.  If  it  appears,  that  these  
compounds share the same functions, other than blocking of T-type channel, the effect 
on the cells might as well be caused by interaction with some other receptor than T-type 
calcium channel. One must also consider the affinity towards the receptor in question. 
Five compounds: ethosuximide, mibefradil, nickel, pimozide and kurtoxin, were chosen 
for experiments because of their relative specificity towards T-type calcium channel. 
Pimozide is the least specific of the substances, and therefore it is interesting to compare 
its action to the other compounds actions.     
 
7.1 Ethosuximide 
 
Inhibition of T-type Ca2+ channels has been proposed to play a role in the therapeutic 
action of succinimide antiepileptic drugs (Coulter et al, 1989). It is being used 
extensively in the treatment of absence epilepsy. Ethosuximide is known to block 
human T-type currents in a state-dependent manner. It is classified as a 2-ethyl-2-
methylsuccinimide (see picture 9). The block of a certain current depends on the 
concentration. According to a study, the detected affinity K I for ?1G and ?1I was 0.3 to 
0.5 mM and for ?1H was 0.6 to 1.2 mM (Gomora JC, et al. 2001). IC50 was 0.6 mM. 
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This study was made on HEK (human embryonic kidney) -293 cells expressing human 
T-type calcium channel subtypes. 
The concentration response curves suggest that there is a biphasic function due to two 
apparent binding sites: a high-affinity (approximately 0.1 mM) site and a low-affinity 
site (approximately 10 mM) (Huguenard, 2002). Anti-absence drugs, such as 
ethosuximide and its active metabolite, MPS (methyl-propylsuccinimide), are known to 
block T-type calcium channels (Coulter et al, 1989). Several electrophysiological 
studies have confirmed these findings (Huguenard and Prince, 1994; Gomora et al, 
2001; Broicher et al, 2007). 
Absence seizures during epilepsy are generated by a rhythmic burst firing between the 
thalamic and cortical neurons. This spike-wave activity is the pathology behind 
generalized absence (GA) epilepsy (Williams, 1953). During periods of slow-wave 
sleep and absence seizures the regular linearly appearing spike-waves in the human 
EEG turn into non-linear burst firing (Livingstone and Hubel, 1981; Hirsch et al, 1983). 
This pattern of activity results from Ca2+- dependent low-threshold spikes generated by 
a transient calcium current, IT, (T-type calcium channel) (Coulter et al, 1989c). There 
are firm evidence that the blocking of Ca2+ channels  is  the  primary  target  for  seizure  
protection in epilepsy treatment and specifically the block of T-type Ca2+ channels is the 
main action of succinimide antiepileptic drugs, such as ethosuximide (Gomora et al, 
2001; Huguenard, 2002). 
There is one study that completely denies the action of ethosuximide on T-type calcium 
channels (Leresche et al, 1998). It is claimed in this study that ethosuximide acts by 
inhibiting the voltage-gated sodium current and the calcium-activated potassium 
current, and that these effects underlie the decrease in burst firing of action potentials. 
Other studies reviewed in here do not have any discrepancies with each other. After all, 
the experimental  conditions in all  of these studies differ in many ways,  although all  of 
them being electrophysiological experiments.   
There are several factors that affect the study results listed in Table 3. Different methods 
are being used, and the cells are excited with different voltage potentials. As one could 
guess, also the cell type used in the study has its affection on the results. Concentration 
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is another thing to note when comparing the results. Among these studies 
ethosuximide’s concentrations vary from 0.7 mM to 3.05 mM. Varying results gained 
with ethosuximide are discussed in an article by Gomora et al. They emphasize that a 
notable difference in these electrophysiological studies is the holding potential (Gomora 
et al, 2001). Since the studies that reported no effect of ethosuximide on T-type 
channels used very negative holding potentials (-110 mV). They suggest that these 
experiments tested block of rested channels, which are less sensitive to block than 
inactivated channels. 
One interesting view is presented in a study of Broicher and his co-workers. Their study 
offers a solution to a current controversy in ethosuximide’s antiepileptic action. 
Combined effects of ethosuximide on several membrane currents (IT, INaP and IKCa) may 
account for the full anti-absence action of therapeutically relevant ethosuximide 
concentrations (Broicher et al, 2007).  
Ethosuximide’s antagonistic action is shown in a number of studies with varying 
methods, cell types and concentrations, as seen in Table 3. 
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Cell type Method ETX 
concentration 
T-type 
Channel 
Other than 
t-type ca-
channels 
Publisher 
WAG/Rij- 
rats thalamic 
neurons 
Whole-cell 
patch-clamp 
EC50 0,21 mM  IT INaP, at 10 
mM,  
Broicher et al. 
2007 
ACI- rats 
thalamic 
neurons 
Whole-cell 
patch-clamp 
EC50 3,05 mM IT INaP, at 10 
mM, 
Broicher et al. 
2007 
Wt- rats 
thalamic 
neurons 
Voltage-
clamp 
0,25-0,75 mM IT not studied Coulter et al. 
1989 
HEK-293- 
cells 
expressing 
human ?1G-, 
and ?1H- 
subunits 
Ruptured 
patch-
method 
K1 2,5 mM 
 
K1 1,9 mM 
?1H- subunit 
(inactivated) 
?1G- subunit 
(inactivated) 
not studied J.C. Gomora 
et al. 2001 
HEK-293- 
cells 
expressing 
murine ?1I- 
subunit 
Whole-cell 
patch-clamp 
35 % reduction at 
3 mM 
?1I- subunit 
(-60 mV)  
not studied Lacinová L. et 
al. 1999 
Wt- rats 
thalamic 
neurons 
Whole-cell 
patch-clamp 
33 % reduction at 
0,7 mM 
IT not studied J.R. 
Huguenard 
and D.A. 
Prince, 1994 
Rats and cats 
thalamic-
cortical cells 
Sharp-and-
patch- 
method 
1 mM no effect 60 % 
reduction of 
INaP at 1mM 
39 % 
reduction of 
IK(Ca) at 0,5 
mM 
Leresche et al. 
1998 
 
 
 
 
 
 
Table 3, Ethosuximide’s antagonistic action 
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Picture 2, Chemical structure of Ethosuximide. Ethosuximides IUPAC- name is 3-ethyl-
3-methylpyrrolidine-2.5-dione. It is classified as a succinimide, which belongs to a 
heterocyclic compound group of pyrrolidines. More precisely, it belongs to a subgroup 
of pyrrolidines, called pyrrolidinones. (PubChem electric database) 
 
 
7.2 Mibefradil 
 
Another low-threshold activated calcium channel blocker is mibefradil, which doesn’t 
have clinical implications anymore (Krayenbühl et al, 1999). Although it seemed to be a 
promising cardiovascular medicine with its ability to decrease blood pressure and heart 
rate with a minimal negative ionotropic effect, as it was observed in clinical trials. This 
non-dihydropyridine inhibitor was approved for use in essential hypertension and stable 
angina pectoris until it was withdrawn from the market because of drug-drug 
interactions leading to irregular heart rhythms. 
 
Mibefradil’s function as an antihypertensive agent was to antagonize T-type calcium 
channels in vascular smooth muscle cells (Mishra and Hermsmeyer, 1994). T-type 
channels in those cells are very sensitive to Mibefradil. 50 % inhibition of T-type 
channels was obtained at 0.1 µM. Mibefradil inhibits both high- and low-voltage 
activated calcium currents, but it has a higher affinity for neuronal T-type over cardiac 
L-type channels. It prefers T-type channels to L-type channels with 10- to 20-fold 
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selectivity. This compound appears to be very effective in blocking calcium channels in 
tissues with less negative resting potential, such as vascular smooth muscle and cardiac 
sinoatrail node (Bezprozvanny and Tsien, 1995; Gomora et al, 1999). However, it 
cannot be used to discriminate between the T-type calcium channel subtypes (Strege, 
2005). Mibefradils action is also dose- and state- dependent (Bezprozvanny and Tsien, 
1995), as in the case of ethosuximide. 
 
Mibefradil’s toxicity is probably produced by blocking also potassium channels 
(Gomora et al, 1999). It is a potent K+ channel blocker, but less selective than as a T-
type calcium channel blocker. Mibefradil is shown to inhibit ATP activated potassium 
channels in adrenal cells with an IC50 value  of  0.50  µM,  a  concentration  that  is  2-fold  
lower (IC50 = 1.0 µM) than that required to inhibit T-type calcium channels in the same 
cells under similar conditions. As a pharmacological agent, mibefradil is problematic 
for two more reasons. It is an inhibitor of cytochrome P-450 (CYP-450) 3A4 enzyme, 
which can result in toxic drug interactions. It is also shown to prolong QT interval with 
other drugs having the same mechanism. This in turn may lead to severe arrhythmias. 
This effect on the cellular level is blockage of potassium channels.     
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Table 4, Mibefradils antagonism in electrophysiological studies 
 
Cell Type Method Mibefradil 
concentration 
T-type 
channel 
Other than 
T-type 
channel 
Publisher 
Rats 
Vascular 
muscle cells 
Whole-cell 
patch-
clamp 
~100 % block 
at 1 µM 
IT 28 % block 
L-type  at  1  
µM 
Mishra S.K. 
& 
Hermsmeyer 
K., 1994 
Gene 
transfected 
Xenopus 
laevis 
oocytes 
Whole-cell 
patch-
clamp 
Kd 3 µM 
Kd 8 µM 
Kd 7 µM 
?1B 
?1A 
?1E 
L-type 
??1C) Kd 22 
µM 
Bezprozvanny 
I. & Tsien 
R.W., 1995 
Gene 
transfected 
HEK-293 
cells 
Whole-cell 
patch-
clamp 
IC50 2,9 µM ?13.3b + ?2 Na+ channel 
(SCN5A) 
IC50 0,98 
µM 
L-type (?1C 
+  ?2) IC50 
2,7 µM 
Strege P. et 
al., 2005 
WAG/Rij 
rats TC 
neurons 
Whole-cell 
patch-
clamp 
100 % block 
at 2 µM 
IT 18  %  HVA  
Ca2+ 
current  at  2  
µM 
28  %  Na+ 
current  at  2  
µM 
Broicher at 
al., 2007 
Gene 
transfected 
HEK-293 
cells 
Whole-cell 
patch-
clamp 
IC50 0,12 µM ?1G not studied Lacinová L. et 
al., 1999 
Bovine 
adrenal zona 
fasciculata 
cells 
Whole-cell 
patch-
clamp 
- not studied IC50 0,50 
µM  IAC 
(ATP- 
activated 
K+- 
channel) 
Gomora J.C. 
et al., 1999 
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Picture 3, Mibefradil’s chemical structure. Mibefradil’s IUPAC- name is [(1S, 
2S)-2-[2-[3-(1H-benzimidazol-2-yl)-propyl-methylamino]ethyl]-6-fluoro-1-propan-2-
yl-3,4-dihydro-1H-naphthal en-2-yl] 2-methoxyacetate. It belongs to heterocyclic 
compounds, and can be classified as a benzimidazole, as well as a tetrahydronaphtalene, 
due to its complex chemical structure. (PubChem electric database) 
 
 
7.3 Nickel 
 
Inorganic divalent and trivalent cations were some of the first chemicals used to block 
T-type currents (Hagiwara et al, 1988). Comparison of the concentrations of drugs 
necessary to inhibit half-maximal T-type currents suggested different rank orders of 
inhibition by different polyvalent cations. The orders were different in varying brain 
areas. This in turn suggests that there is heterogeneity between the subtypes, because of 
their division throughout the CNS varies. Several cations, such as La3+, Zn2+, Cd2+, Ni2+ 
(Ye and Aikaike, 1993) inhibit T-type channels.  
 
It has been known for over a century that di- and trivalent cations act on cells’ 
electrophysiology. Nickel has been considered as a T-type specific calcium channel 
antagonist. Some studies cast doubts on its specificity (Gloding et al, 1999), while 
others state that the specificity is dose-dependent. T-type specificity has been recorded 
at a concentration range from 5 to 50 µM (Biagi and Enyeart, 1991), and HVA-affection 
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from 216 to 250 µM (Lee et al, 1999). There can also be differences between the three 
cloned T-type receptor subtypes. It is shown, that nickel is specific only to the subunit 
?1H, and the higher concentrations needed for blocking the two other subtypes block 
also HVA- channels (Lee et al, 1999). 
 
One study revealed that also Ni+ has interaction with potassium channels (Golding et al, 
1999). In this study >0.5 mM nickel was needed to block calcium spikes completely in 
CA1 pyramidal neurons. Conversely effect was seen in local application of nickel to the 
soma and adjacent dendrites. Nickel increased reversibly the number and/or width of 
calcium spikes compared to control cells. The authors suspected that this increased 
excitability could be explained by a reduction in the activation of calcium-activated 
potassium channels through blockade of calcium influx by Ni+. 
 
What comes to nickels selectivity among T-type calcium channel subtypes, only ?1H 
subunit is blocked by micromolar concentrations of Ni+ (Lee et al, 1999). The higher 
concentrations that are needed to block the other T-type calcium channel subtypes also 
blocked HVA calcium channels. Similar observations were made in another study, 
where T-type current was selectively blocked by Ni+ at concentrations between 5 and 50 
µM (Biagi and Enyeart, 1991) (see Table 3). In this study, trivalent cations lanthanum 
La3+ and yttrium Y3+ blocked T current at 10- to 20-fold lower concentrations in thyroid 
C-cell line. However, these cations are not selective for T-type channels, as they also 
block L-type calcium channels.  
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Table 5, Nickels antagonism in electrophysiological studies 
Cell Type Method NiCl- 
concentration 
T-type 
channel 
Other than 
t-type 
channel 
Publisher 
Rat 
medullary 
thyroid 
carcinoma 
cells 
Whole-cell 
patch-
clamp 
T-type 
selective at 5-
50 µM 
IT not studied Biagi B. & 
Enyeart J., 
1991 
Gene 
transfected 
HEK-293 
cells 
Whole-cell 
patch-
clamp 
IC50 13 µM 
IC50 216 µM 
IC50 250 µM 
?1H 
?1I 
?1G 
HVA- 
channels at 
216 and 
250 µM 
Lee J. et al., 
1999 
Wistar rats 
hippocampal 
cells 
Whole-cell 
patch-
clamp 
100 % block 
at 500-1000 
µM 
IT IK(Ca) 500 
µM 
HVA 
channels at 
500-1000 
µM 
Gloding N. 
et al., 1999 
Gene 
transfected 
HEK-293 
cells 
Whole-cell 
patch-
clamp 
IC50 470 µM ?1G not studied Lacinová L., 
et al., 1999 
 
 
7.4 Pimozide 
 
Antipsychotic drugs’ selectivity has been an issue for recent decades. Since the first 
antipsychotic drugs were invented, their effect of action was mostly based on a 
dopaminergic D2- receptor antagonism (Koulu and Tuomisto, 2007). This effect has 
lately been related to their typical side-effects worsening the so-called negative 
symptoms  of  schizophrenia;  social  exclusion,  passivity  and  poverty  in  speech.  The  
newer antipsychotic drugs’ effect of action is based on antagonism on more than just 
one receptor. 
An antipsychotic drug, Pimozide belongs to a chemical group of 
diphenylbutylpiperidines, DPBPs (Santi et al, 2002). Its mechanism of action is 
believed to be mainly blocking the dopaminergic receptor D2.  One  of  the  more  recent  
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studies  show  that  its  mechanism  of  action  is  as  much  of  blocking  the  receptor  D2 as 
blocking of the T-type calcium channel. This might explain the drug’s clinical 
improvement to the negative symptoms of schizophrenia, compared to the classical 
antipsychotics potently blocking the dopaminergic receptor subtype D2. 
Pimozide blocks cardiac HERG potassium channels with a high affinity, as well as the 
neuronal HERG potassium channels (Jiesheng et al, 2001). Drugs that block cardiac 
HERG potassium channels are known to prolong the QT interval on the 
electrocardiogram via this channel blockage (Brown and Rampe, 2000). In addition to 
pimozide, some other drugs also have this effet. These drugs include certain 
antihistamines, antibiotics and a few other antipsychotics. 
 
Table 4, Pimozides antagonism in electrophysiological studies 
Cell Type Method Pimozide 
concentration 
T-type 
channel 
Other than 
T-type 
channel 
Publisher 
Gene 
transfected 
HEK-293 
cells 
Whole-cell 
patch-
clamp 
Kd 43,5 nM 
Kd 57,7 nM 
Kd 39,2 nM 
?1G 
?1H 
?1I 
not studied Santi C. et 
al., 2002 
  Kd 29 nM not studied D2 
(dopamine) 
Richelson & 
Souder, 
2000 
Gene 
transfected 
Chinese 
hamster 
ovary cells 
Whole-cell 
patch-
clamp 
IC50 103 nM not studied erg3 (human 
neuronal  K+ 
channel) 
Kang J. et 
al., 2001 
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Picture 5, Pimozide’s chemical structure. Pimozide’s IUPAC- name is 3-[1-[4.4-bis-(4-
fluorophenyl)-butyl]-piperidin-4-yl]-1H-benzimidazol-2-one. It belongs into a benzimidazoles 
group of heterocyclic compounds. (PubChem electric database) 
 
7.5 Kurtoxin 
 
Kurtoxin is a 63 amino-acid protein toxin from the venom of a South African scorpion 
(Parabuthus transvaalicus) (Chuang et al, 1998). It blocks specifically the ?1G T-type 
calcium channel. In the study of Chuang et al., kurtoxin inhibited ?1G T-type calcium 
channels by over 95 % and ?1H channels  by  85  %  at  a  concentration  of  350  nM.  
Kurtoxin distinguished between ?1G and the high-voltage activated calcium channels 
with over 600-fold selectivity. It also interacts with voltage-gated sodium channels and 
slows their inactivation. This is also noted in another study reporting that ?300 nM 
kurtoxin inhibited the peak amplitude of voltage activated Na+ channel at ?10 mV (Zhu 
et al, 2009), which is approximately ten times higher than the concentration of kurtoxin 
that is specific for T-type calcium channel. The authors emphasized that many channel 
blockers are non-specific, if used at high enough concentrations. Kurtoxin can be 
considered as a high-affinity blocker of T-type calcium channel (Chuang et al, 1998). 
 
In a study made with thalamic neurons, 500 nM kurtoxin resulted in almost complete 
inhibition of T-type calcium currents (Sidach and Mintz, 2002). 90.2 % of the currents 
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were inhibited. Its selectivity was lower than the researchers expected because it also 
reduced the composite high-threshold calsium channel current in the cells by 46.1 %. 
According to the studies described above, this was probably because of the relatively 
high concentration used in the study. 
Peptide toxins are valuable tools for studies of voltage-gated ion channels (Sidach and 
Mintz, 2002). Although the origin of these proteins may be diverse, their modes of 
action fall within two major categories. Pore-blocking toxins bind to the external 
vestibule of the channel pore and physically obstruct the movement of ions (MacKinnon 
and Miller, 1988). Gating modifiers bind to the channel voltage sensor and alter the 
energetics of voltage-dependent gating (Cahalan, 1975). Kurtoxin is a gating modifier 
that stabilizes the closed state of the channel, so that it requires larger depolarizations in 
order to gate into the open state. It binds to T-type channels extracellular protein chains 
S3-S4  linker  of  domain  IV  close  to  the  voltage  sensor  (Chuang  et  al,  1998).  The  
conclusion of kurtoxin being a gating modifier is strengthened by the sequence 
homology between kurtoxin and the alpha-scorpion toxins, a group of well studied 
toxins that modify the gating of sodium channels. Chuang and his co-workers suspected 
that the voltage-sensing domain in repeat IV of T-type calcium channel’s quaternary 
structure contains a competent kurtoxin binding site. The researchers got the clue of 
their experiments indicating a 1:1 stoichiometry between toxin and channel.  
In the study of Sidach and Mintz, also some problematic aspects of kurtoxin appeared. 
Accurate measurements of kurtoxin rate constants were impaired because of toxin 
nonspecific binding to glass capillaries, or its nonhomogeneous application into the 
minichamber used in the measurement. The authors advice that all the glass material, 
including vials and recording chamber, that is in connection with kurtoxin, should be 
siliconized to minimize toxin loss via nonspecific binding. 
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Table 6, Kurtoxin’s antagonistic action in electrophysiological studies 
Cell Type Method Kurtoxin- 
concentration 
T-type 
channel 
Other than 
t-type 
channel 
Publisher 
Xenopus 
oocytes 
Patch-
clamp 
95 % block at 
350 nM 
?1G INa Chuang R. 
et al. 1998 
Rat 
thalamic 
neurons 
Patch-
clamp 
90,2 % block 
at 500 nM 
IT HVA-
calcium 
channels 
Sidach S. 
and Mintz I. 
2002 
Mice 
smooth 
muscle cells 
Patch-
clamp 
?300 nM not studied INa Zhu H-L. et 
al. 2009 
 
 
As seen in the Table 1, not all the studies agree on the ethosuximide’s specificity on the 
low-voltage activated calcium channels. These differences could be explained by the 
experimental procedures. The action of ethosuximide is shown to be both dose-
dependent and state-dependent (Gomora et al, 2001). The channel’s state depends on 
the holding potential in electrophysiological studies. T-type channel can be activated 
with small depolarizations into the range near -60 mV that did not activate other 
currents (Huguenard and Prince, 1994). There are certain differences in 
electrophysiological methods. For example, the whole-cell measurements differ in many 
factors from the sharp-electrode recordings (Staley et al, 1992). Such a specific and 
selective drug hardly exists, that it wouldn’t have side effects due to its affinity to a 
substrate other than its desired pharmacological target. 
As seen in the Table 1, 2, 3 and 4, all these T-type specific substances have affinity to 
the voltage gated potassium channel, IK.  One reason for a drug to be rejected from the 
pre-clinical trials is that it binds to cardiac HERG (human ether-a-go-go-related) 
potassium channels. That is because there is a high risk of prolonged QT- time and 
severe antiarrhythmias if a drug binds to this receptor, which was the case of 
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ethosuximide being withdrawn from the market (Leresche et al, 1998). Binding to 
cardiac HERG potassium channels is dangerous, especially when there is a drug-drug 
interaction of two different drugs used at the same time that bind to this channel. This, 
in turn, was the reason for mibefradil being withdrawn from the market. Paradoxically, 
these cardiac HERG potassium channels are one primary target for the pharmacological 
management of arrhythmias (Kiehn et al, 1999). The class III antiarrhythmic drug 
amiodarone is used to block these potassium channels. The patients are being controlled 
regularly and any usage of other drugs that are known to affect this channel is 
forbidden. 
Since these compounds listed above seem to have some kind of affinity to potassium 
receptors, it was evident to apply one more substance to the experiments. Kurtoxin, a 
peptide toxin, does not seem to have interaction with potassium channels, according to 
the published research. 
All of these pharmacological substances act on T-type calcium channels, but affect also 
other voltage-activated ion channels. Most of the substances: ethosuximide, mibefradil, 
pimozide and nickelchloride are also known to block potassium channels. Mibefradil, 
nickel and kurtoxin also block high-voltage activated calcium channels at higher 
concentrations. T-type channels seem to be not only low-voltage activated, but also 
affected by lower concentrations of ligands. The reason why the substances that bind to 
T-type channels affect also other channels is probably the genetic similarity of these 
channels (Perez-Reyes, 1999). Voltage-gated calcium channels are part of a superfamily 
that includes the highly related sodium channels and more distantly related potassium 
channels (Jan and Jan, 1990). Not one of these pharmacological or toxicological 
compounds are considered as specific T-type channel blockers. Many studies confirm 
their selectivity while some others disagree. This contradiction raises a question of what 
exactly  is  specificity.  In  the  light  of  the  fact,  that  there  are  no  absolutely  specific  
pharmacological substances that would not affect any other thing in the body than their 
desired target, the essence of specificity is, if not outright a dogma, then at least a 
relative term.  In spite of that, if all of these T-type blockers listed above are used in the 
experiments of this study, it is likely that the results are valid to show a tendency of the 
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pattern, in which the cells are affected by blockage of T-type calcium channels. This is 
even more likely if the concentration of the substance to be used is relevant. 
 
 
8. Structure of T-type channel 
 
Conservation of amino acid sequences and predicted secondary structure indicate that 
T-type channels are evolutionarily related to potassium, sodium and HVA channels, and 
together they form an ion channel superfamily (Jan and Jan, 1990). Although the 
sequences are genetically alike, and the secondary structures are quite similar, the level 
of homology is actually rather low. Many amino acid substitutions differ as changes in 
hydrophobic residues such as leucine, which is often replaced by other hydrophobic 
residues, such as isoleucine, valine or phenylalanine. 
 
Structural motifs, which are three-dimensional structural elements within the chain, are 
repeated four times in T-type channels. They are polypeptides of four homologous 
domains (I-IV), each of them containing six transmembrane spans (S1-S6), and 
cytoplasmic N- and C-termini. These are also the four voltage-sensing domains in the 
ion channel. Three intracellular linkers (I–II, II–III and III–IV) connect the four 
domains. Repeats are usually marked with roman numbers. Ion channels are often 
represented by snake diagrams, where the protein is shown to snake its way through the 
membrane (Picture 6). 
 
As seen in the picture 6, clearly the most of the protein is situated in the cytoplasm and 
the only significant extracellular portion is at the pore loop in repeat I. Also the terminal 
chains N and C are located in cytoplasm. A conclusion of this physiological position is 
that T-type channels have also important intracellular activities. It has indeed multiple 
putative phosphorylation sites, which are determinant for the modulation by several 
protein kinases, including protein kinase A (PKA), protein kinase C, tyrosine kinase and 
Ca2+/calmodulin kinase II (CaMKII) (Yunker and McEnery, 2003). Furthermore, many 
55 
 
intracellular molecules can modulate endogenous T-type currents, including GTP, 
cGMP dependent protein kinase and protein tyrosine kinases, suggesting activation of 
many pathways can alter T-type currents. Also there is a great deal of heterogeneity in 
the  responses  of  different  T-type  channels  to  many  of  these  hormones  and  
neurotransmitters. For example, T-type currents may be increased, decreased, or not 
affected by the beta-adrenergic receptor agonists, norephinephrine and isoproterenol. In 
addition, GABA, substance P, and serotonin can either attenuate or potentiate T-type 
currents recorded in a variety of neurons (Yunker, 2003). 
 
 
Picture 6, Snake diagram of CaV3 transmembrane protein with its four repeats (Adapted 
and modified from Perez-Reyes, 1999) 
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9. Building of the Cell-IQ library 
 
When the key interests in this study are the movement and morphology of the cells, in 
addition to all the other possible phenomenons that can be detected, Cell IQ provides an 
excellent tool for performing the experiments. Cell IQ is a cell incubator equipped with 
a camera (Korhonen et al, www.smts.fi, 2008). It is made in cooperation with Chip-
Man Technologies Oy, VTT (Valtion teknillinen tutkimuskeskus) and the University of 
Tampere’s Center of Cell Research. With this hardware, one can perform picture and 
video analysis using imaging software. The temperature and gas composition inside the 
incubator  can  be  regulated  with  the  additional  software.  In  addition  to  the  videos  and  
pictures  one  can  make  with  Cell  IQ,  it  can  also  be  used  as  an  analyzing  tool.  By  
defining the properties of the cells and their background, the software is able to count 
the number of the cells and export the data to Excel-software (Cell IQ user manual, 
Chipman-Technologies, 2010). Cell-IQ can recognize, not only the total number of the 
cells, but also different cell populations, when they are defined and saved to the 
protocol. Analyzing software is also commercially available for a range of different cell 
and tissue types. Building an analyzing protocol by oneself, is reasonable when 
considering the economical savings and the selectivity of the protocol for your own cell 
culture and experimental set up. Cell IQ Analyzer is able to count cells in thousands of 
pictures taken during several days only in a few hours. One can just imagine how long it 
would take for a researcher to count that number of cells.  
The process of building a library begins with building a protocol. In a protocol four 
parameters  will  be  set  to  suit  best  the  experiment  in  question.  Those  are  segment  
gradient threshold, cell distance, maxim cell diameter and cell symmetry. With segment 
gradient threshold, the contrast of the image can be set either to reduce background or 
increase the threshold so that the analyzer counts also the cells that fade into the 
background. The numbers of these parameters depend on the cells and the matrix they 
grow in. Solving out the appropriate value of the parameter just requires trying different 
values  and  comparing  the  results.  An  easy  way  to  validate  the  results  counted  by  the  
program is to count them manually, and see if the numbers are equal. When the 
population of differentiating stem cells increases, the cells form connections and 
networks in multiple layers. In this case, the cell distance should be set low, so that 
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analyzer counts the cells that are closely connected to each other. By setting maxim cell 
diameter big enough and the value of cell symmetry high, one can avoid analyzer 
counting debris as cells. 
After making the protocol, gathering samples for the library can start. Introducing these 
samples to the analyzer teaches it to recognize certain kind of similarities, and count 
them into a same group, as seen in picture 7. 
 
 
Picture 7, Example of cell count curve made by the analyzer. Cell number is on the y-
axis and time on the x-axis. This analysis is made of 2 days and 10 hours period. Total 
cell number is marked with a white line, slow-type cells with a green line, fast-type cells 
with a red line, edge of the sphere with a purple line, background with a blue line and 
debris with a turquoise line.  
 
 
There is a possibility to create as many groups of items as needed. In this experiment six 
different groups were formed for cell counting. These are debris, edge, background, 
dividing cells, fast type and slow type. Fast and slow type cells were created to 
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distinguish two different cell populations, one of them being smaller and faster, and the 
other clearly slower and glia-like. Naming them neurons and glial cells solely according 
to their morphology would be misleading. In a good library the samples are alike, the 
pictures resolution is decent and the item is set in the middle of the picture. Below there 
are listed some samples from the library.  
 
Fast type-cells 
 
 
 
 
Slow type-cells 
 
 
 
 
The edge of the sphere was defined to separate the sphere from the migrating cells. If 
the aim is to count migrating cells, it is reasonable to leave the sphere out of counting. 
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Another thing to be set  is  the background, so that it  differs from the cells.  Also all  the 
debris can interfere with cell counting and should therefore be defined. One thing of 
interest was to detect cells division. Dividing cells were set as a one separate group. 
There are some picture samples of these four groups, edge of the sphere, background, 
debris and dividing cells. 
The more pictures there are in the library, the better is the software’s ability to 
recognize cells. On the other hand, every picture changes the whole library, and all the 
differences between the cells make more parameters for the program to count. This in 
turn creates a risk of making the library disorderly only by adding too many samples. 
The manufacturer recommends the number of samples in each group to be set around 
twenty. 
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Edge of the sphere 
 
 
Background 
 
 
Debris 
 
 
Dividing cells 
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9.1 Optimizing the method 
 
Creating the first version of the protocol resulted in an error rate of 27 % in counting the 
cells.  This means that the number of cells counted by the analyzer differed 27 % from 
the number of cells that was counted manually. Because of these rather poor results, 
some development of the protocol had to be done. Analyzer counted too many cells, so 
it  could  be  concluded  that  it  counted  as  cells  something  else  than  the  actual  cells.  It  
could be seen on the screen that it counted debris as cells. This is easy to notice, because 
the program marks the counted cells with colored dots. Introducing more samples of 
debris to the analyzer teaches it to recognize different kind of debris. After increasing 
the number of debris samples by 28, the correspondence of the cells counted by the 
analyzer compared to the cells counted manually, increased. The percentage of 
correspondence reached 82 %, meaning it was now 9 % more accurate than before. 
A crucial move was decreasing moderately the number of gradient threshold, when the 
analyzer separates fewer objects from the background than before. Usually this means 
that it counts less of the background objects, which is the intension. This change 
decreased the error rate to 7 %, although with a standard deviation of 6.29. 
This accuracy was sufficient for the experiments considering that the changes do not 
always result in a better protocol. They might even have opposite effects. However, 
whether the error rate is high or low, the tendency of the cell count curve is always the 
same. For example, if the analyzer counts 7 % more cells than there actually are the 
increasing cell number results in the same percentage or ratio of cell growth. 
 
9.2 Cell IQ in studying stem cells 
 
When starting to study the stem cells differentiation, it is important to identify the 
various  cell  types  that  are  developing  (Kolb,  2007,  www.biotech-online.com). During 
the  very  first  hours,  it  is  essential  to  detect  and  record  data  from  the  culture.  At  this  
time, some crucial information is gained at the moment when the different cell types 
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appear and the time each event begins, and how long they last for. This is easy with on-
line  recording,  which  is  possible  with  Cell  IQ.  Videos  can  be  watched  afterwards,  so  
this is really a time saving method. 
 
All  kinds  of  events  can  be  monitored  with  the  help  of  Cell  IQ. Practically, any 
morphological parameter that can be detected by naked eye can be analyzed and 
quantified by Cell-IQ (www.chip-mantechnologies.com, page browsed on 11/2010). 
These parameters can be for example cell number, cell viability, cell division, cell 
death, morphological parameters, cell movement, analysis of selected single cells in the 
cell  culture,  and  analysis  of  structures  composed  of  groups  of  cells  in  cell  culture.  All  
these parameters listed above can be defined to the program, analyzed by the analyzer 
and then put to a form of quantitative data with plots and diagrams. Another advantage 
of this method is that no labels are needed to gain all the data. Toxic and 
pharmacological compounds can be added to the culture to study their effect on the 
cells. The software counts the cells dead and living, as long as they are listed in the 
library. 
 
 
  
Picture 8, an example of quantitating cell viability of a cell population with Cell IQ. In 
this picture the number of dead cells is approximately 18 and the number of living cells 
is approximately 134. These numbers are counted by the analyzing software. (Adapted 
and modified from www.chipmantechnologies.com) 
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10. Research questions 
 
One  aim  is  to  indicate  the  functional  significance  of  T-  type  calcium  channel  in  what  
comes  to  the  migration  of  NSC’s.  The  cells  that  were  examined  in  this  study  were  
derived from the mice brains’ SVZ at the embryonic day 14, which is known to be the 
climax of the neurogenesis. This study focuses on the migration and T-type calcium 
channels as possible modulators of this episode. 
Finding specific information about the functions of stem cells and what conducts them 
in their differentiation leads us closer to benefit from this self-renewing and multipotent 
source of reserve in all of us. When the transplantation and other invasive strategies in 
the stem cell therapies come to their end, due to the laborious and costly implement to 
healthcare, pharmacology takes place. This need is described in an article of Meletis et 
al as: “The development of pharmacological strategies to modulate endogenous stem 
cells and their progeny may be an attractive alternative to cell transplantation for the 
treatment of spinal cord injury.” (Meletis et al, 2008). Since stem cells construct all the 
tissues and parts of the body, they can be used to reconstruct any cell type in the cases 
of injury or degeneration, or just a genetic lack of a certain cell type. 
Conducting stem cells to the way we want and differentiating them to the types needed 
is definitely a challenge. Taking into account the variety of factors that affect SCs, the 
question is: What their role in the process is, and whether there is a hierarchy between 
them. Even though this abundance of factors is a challenge, we must keep in mind that 
it is also a possibility. 
The role of calcium channels in neurogenesis has been proven to be essential. The 
specific  role  of  T-type  calcium  channel  is  interesting  for  several  reasons.  Firstly,  it  is  
widely expressed at the beginning of neuronal development, decreasing constantly by 
the maturation of neurons. It is shown in a few studies that it also has functional 
significance in the early development. Secondly, it is one of the least studied calcium 
channels, so the opportunity for fundamental research exists. T-type channels play 
important roles in a range of neurological actions such as sleep, learning, memory and 
different kinds of electrophysiological oscillations in CNS. Therefore, there is a reason 
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to assume they would also possess an essential place in neurogenesis. One intriguing 
property of T-type channel is that it is already a pharmacological target with some 
antagonists commercially available, although they were later withdrawn. 
The  aim  of  this  study  is  to  indicate  the  role  of  T-type  calcium  channel  during  the  
migration, and consider the pharmacological possibilities it brings. This study together 
with the literature review is in its place to raise the interest towards the action of T-type 
channel and the pharmacological potential that it shows. 
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EXPERIMENTAL PART 
 
 
11. Materials and methods 
 
 
11.1 Cell cultures 
 
The central nervous system’s stem cells were derived from mice brains at embryonic 
day 14, from the area known as the subventricular zone. The cells were incubated for 3 
days in the culture medium consisting of 2 mM l-glutamine, 15 mM HEPES, 100 U/ml 
penicillin, 100 mg/ml streptomycin and 1:50 B27 supplement in DMEM-F12 medium 
(Life Technologies), at 37 ?C in 5 % CO2 in an air ventilated humified incubator. In the 
medium the cells formed free floating neurospheres. As soon as the size of the diameter 
of neurospheres increased to approximately 200 µm, they were dissociated 
mechanically by pipetting back and forth. Then the cells were centrifuged for 5 minutes 
at 800 rpm. After that, they were resuspended and plated in the culture medium. 
Neurospheres were passaged every 7-9 days. 
Every third day two growth factors were added to the culture medium, epidermal 
growth factor, EGF (Life Technologies) and fibroblast growth factor, FGF (PeproTech 
EC Ltd., London, UK), in concentrations of 20 ng/ml and 10 ng/ml, respectively. The 
growth medium was refreshed once a week by changing half of it to a new medium, and 
was changed completely approximately once a week, depending on the condition of the 
medium. 
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11.2 Immunocytochemistry 
 
A series of neural stem cells were differentiated for this experiment for 7 days on cover 
slips. Three of them were fixed on differentiation day 1, 3 on day 3, 3 on day 5 and 3 of 
them on day 7. NSC cells on cover slips were fixed for 10 minutes at room temperature 
(RT) with 4% paraformaldehyde (PFA) in PBS (pH 7.4) and then rinsed twice with PBS 
for 5 minutes. The cells were then permeabilized with ice-cold methanol for 20 minutes 
and rinsed twice for 5 minutes with PBS. To prevent the non-specific binding of the 
antibodies, the cells were treated for 20 minutes in RT with 20% normal goat serum 
(NGS,  Chemicon  International,  Temecula,  CA,  USA)  in  PBS.  Next  the  cells  were  
incubated with ?- tubulin III specific antibody, Tuj-1 and T-type specific antibody (both 
from Sigma-Aldrich) over night in +4?C. The cells were then washed three times for 5 
minutes with PBS and stained with goat anti-rabbit Alexa 488 and 568 secondary 
antibodies (Molecular Probes, Invitrogen, 1:500) in 37?C for 1 hour. After that the 
washings with PBS were repeated. The nuclei of the cells were counterstained with 4’6-
diamino-2-phenylindole (DAPI) (Boehringer Mannheim Biochemica, Germany, 
1:10000). The cover slips were rinsed again with PBS and mounted with Gel MountTM 
Aqueous Mounting Medium to glass slides. T-type calcium channels were detected with 
a laser scanning confocal microscopy was performed with LSM 5 Pascal system (Zeiss). 
Brightness and contrast of the obtained images was adjusted with Corel Draw Graphics 
Suite X3 (Corel). Tuj-1 was detected with a fluorescence microscope (Olympus) using 
objectives of 10x, 20x and 40x.  To control the specificity of the antibodies primary or 
secondary antibody were left out from some of the samples. 
 
11.3 Blocking of the T-type calcium channels 
 
Three experiments were made to block the T-type calcium channels of the cells, to 
detect  what  happens  when  the  cells  are  grown  in  the  presence  of  a  T-type  channel  
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blocker and after two days of differentiation. Three pharmacological substances were 
used that are known to block T-type channels. 5 mM ethosuximide, 1 mM 
nickelchloride, NiCl2, and 300 nM kurtoxin (all from Sigma-Aldrich) were used to 
block the channels. Ethosuximide was diluted in alcohol, NiCl2 in aqua purificata and 
kurtoxin in HEPES. Concentrations of the substances were determined according to the 
literature review in Literature part, chapter 5.2. 
Before plating the cells to the 6- well-plate, the bottom of the plate was covered with a 
protein called poly-l-ornithin. This fibre-like protein makes the surface uneven, and 
therefore beneficial for the cells to attach to the plate. To prevent the protein from 
drying  out,  it  was  covered  with  Elliot’s  salt  solution.  Cell  incubation  assay  with  Cell-
IQ® (Chip-Man Technologies Ltd., version 2010) equipped with CCD-camera (Nikon), 
10x objective,  0,7 µm resolution, was always carried out using the same method. A 6-
well plate was filled with 4 milliliters of medium, and the substance to be examined was 
added to two wells. The plate was coated with Poly-l-ornithine the day before the 
experiment. Cells were plated on each well of the plate. The cells were left to attach to 
the  plate  for  30  minutes.  After  that  the  plate  was  inserted  to  the  Cell-IQ-  imager  that  
started continuously imaging pictures with a five minutes interval in between of each 
cycle.  Cell  IQ took  pictures  from every  6  well  and  every  9  determined  position.  After  
two  days,  the  medium  was  refreshed  by  changing  half  of  it  and  the  pharmacological  
substances were added, so that the final concentration was approximately the same as in 
the beginning of the experiment. To see if the pharmacological substance had any effect 
on the cells that already had started their migration, the compound was added to two 
more wells after two days of incubation, leaving two wells free of treatment. The same 
concentration was used as in the beginning of the incubation. Each experiment 
continued for at least four days. 
All the experiments were made by controlling the parameters that might affect the 
results. The same fixed protocol was used at every experiment. The amount of spheres 
in  a  well  was  15-20  and  the  diameter  of  one  sphere  was  approximately  200  µm.  It  is  
important to select spheres with a bright center that marks the viability of the cells. 
Center  of  the  sphere  being  dark  is  a  sign  of  apoptotic  cell  death  in  the  middle  of  the  
sphere.  When  the  stem  cells  divide  symmetrically  they  produce  identic  daughter  cells  
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with an ability of self-renewal and multipotency. Symmetrical dividing leads to a 
symmetric round sphere. Therefore choosing symmetric and round spheres is essential 
for maintaining a culture of multipotent undifferentiated cells. 
Another thing to consider was the number of the spheres in a selected imaging position. 
That number was defined to be <5 or ?5 spheres, that were comparable with each other. 
This is because of the growth curve is similar in each group of spheres. When grown 
and differentiated in medium, cells begin to divide and migrate rapidly, but after the 
first two days the fast growth exceeds its limit. During those first days the growth 
follows a logarithm or even a sigmoidal scale ending at a lag-time followed later by 
apoptotic  cell  death.  That  is  why  the  first  hours  and  the  first  days  are  so  critical  and  
interesting to examine. In the case when there are several spheres growing near to each 
other, the growth curve turns to decline, simply because of the lack of space for the cells 
to live in and migrate, as seen in the picture 10. This is the reason why the number of 
spheres in a position was set to <5 after the nickel experiment. If that was not possible 
for  some reason,  then  the  positions  with  <5  spheres  and  the  positions  with  ?5 spheres  
were pooled together. 
 
 
 
 
 
 
 
 
Picture 9, the growth curve of positions with <5 spheres compared to positions with ?5. 
Growth is described as a percentual change to the maximum cell number during the 
incubation. Growth curve on the left presents the positions with spheres <5. 
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Although the main parameters are controlled, there are still several uncontrolled 
variables when examining living organisms. To obtain reliable results, the number of 
migrating cells is announced as a procentual or a relative change compared to the 
beginning. This is made to normalize the data. Counting the number of the cells outside 
the sphere indicates the number of migrating cells. The raw data was analyzed with 
Excel, and Origin™ 7.0 was used for further analysis. Results were expressed as mean 
± standard error (SEM). Student's t test was used in analyzing data for cell incubation 
measurements. A p-value less than 0.05 was regarded as statistically significant. 
 
11.4 HEK-cells 
 
HEK-cells, human embryonic kidney cells, offer an excellent assay system as a negative 
control to T-type calcium channels, since they do not express voltage gated calcium 
channels, and contain very little background currents under appropriate assay conditions 
(Gomora et al, 2001). The cells were grown in standard Dulbecco’s modified Eagle’s 
cell culture medium (DMEM; Invitrogen) supplemented with 10 % fetal bovine serum 
(Invitrogen), 100 U/ml penicillin-streptomycin solution (Invitrogen), at 37 ?C in 5 % 
CO2 in an air ventilated humified incubator in 260-ml culture flasks (Nunc A/S, 
Roskilde, Denmark). 
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12. Results and performing of the experiments 
 
12.1 Blocking of the T-type calcium channel 
 
12.1.1 Experiment 1: Examining the effect of nickel on the cells 
 
In this experiment, 1 mM nickelchloride was used to examine its effect on the cells’ 
migration.  Movements  and  morphology  were  detected  with  Cell-IQ.  The  events  were  
recorded with Cell IQ video camera during a 6 days period. 
On the first day, a 6-well plate was filled adding nickelchloride to only one well, 
otherwise the procedure was peformed according to the manner described in Materials 
and methods (Blocking of the T-type calcium channels). In this experiment, passage 9 
cells were used. 
On the second day, the results were examined online, while Cell-IQ continued the 
imaging. In the nickel-well, a clear change had taken place in comparison with the 
control wells. The cells were set on the edge of the sphere, and hadn’t started migrating 
away from the sphere, like the cells in the control plates did. The control cells had 
migrated far and achieved different developmental stages on their way. After 24 hours, 
there was a statistically significant difference (p < 0.05) between the migrating control 
cells and the nickel-treated cells (picture 11). 
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Picture 11, relative difference in cell number compared to the beginning after 24 hours of 
incubation.  N  =  number  of  wells,  n  =  number  of  spheres.  The  cells  grown  in  the  presence  of  
nickelchloride were significantly lower in their number (p < 0.05) than those grown in the 
control wells. 
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Picture 12, cells grown in the presence of nickelchloride compared to the growth of control 
cells. The growth in the presence of nickelchloride is significantly slower. 
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To see if nickelchloride had an effect on the divided and migrated cells, 1 mM 
nickelchloride  was  added  to  two  more  wells,  on  the  third  day  of  the  experiment.  The  
wells were taken out of the Cell-IQ- incubator, 2 milliliters of new medium was added 
to the wells with nickelchloride, so that the final concentration of it was the same 1 mM 
as before, as described in Materials and methods. 
On the day 4 the cells were observed and it was noticed that after adding nickelchloride, 
all cells in the nickel-wells seemed to be set on their places, and they had stopped 
moving. If  the cells stay still  for too long, they die.  In this case there were no signs of 
acute cell death. There were no detectable signs of cell death. The number of migrating 
cells outside the sphere was equal in the control- and nickel wells before adding 
nickelchloride (picture 13), but significantly higher (p < 0.05) in the control well, than 
in the nickel well after adding the substance (picture 14). 
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Picture 13, relative difference in the cell number before adding nickelchloride to the wells, at 12 
hours of incubation. There is no significant difference between the controls.  
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Picture 14, cell number outside the sphere was significantly lower when grown in the presence 
of nickelchloride added after 2 days of incubation. At the final measure point, (120 hrs) there 
was a statistically significant difference (p-value <0.05) between the control and the nickel 
wells concerning the number of the cells migrating outside the sphere. 
 
The  same  results  can  also  be  demonstrated  as  a  cell  growth  curve  during  the  whole  
experiment (picture 15).  
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Picture 15, the number of cells outside the sphere during 120 hours of incubation. 
Nickelchloride was added on the second day, and after that the growth slowed down. 
 
12.1.2. Experiment 2: Examining the effect of ethosuximide on the cells 
 
When the cells were grown in the precesence of ethosuximide, the migration of the cells 
was significantly slower than in the control wells (picture 17). After 24 hours, the 
number  of  cells  was  increased  1.6-fold  in  the  control  wells,  and  1.2-fold  in  the  ETX  
wells (p <0.05) (picture 16). 
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Picture 16, cells grown in the presence of 5 mM ethosuximide compared to the control. Number 
of cells migrating after 24 hours as a relative change in cell number compared to the beginning. 
N = 2, n(Ctrl) = 48, n(ETX) = 62 
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Picture 17, cells grown in the presence of ETX during 70 hours time. Cell growth expressed as a 
relative change compared to the beginning. 
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Ethosuximide, 5 mM was added after 36 hours of incubation. The effect of 
ethosuximide was not as clear as when grown in the presence of this substance, as seen 
in the picture 18. When the relative growth was compared after 24 hours since adding 
ETX to the cells, there was no statistical difference between control and ETX wells  p = 
0,17703 (picture 19). 
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Picture 18, relative change in the cell number compared to the beginning during 70 hours of 
incubation. ETX was added to the wells at 36 hours of incubation, black arrow. 
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Picture 19, relative change in the number of migrating cells after 24 hours of adding ETX to the 
wells. There is a difference between the groups, but it is not statistically significant. N = 2, n = 
19 
 
12.1.3. Experiment 3. The effect of kurtoxin on the cells 
 
Cells were grown in the presence of a T-type calcium channel specific blocker, scorpion 
toxin named Kurtoxin at a concentration of 300 nM. There was a slight difference 
between the kurtoxin and the control wells after 24 hours of incubation, but it was not 
statistically significant, p = 0.14261 (picture 20). During the 70 hours incubation the 
cells in the kurtoxin wells seemed to migrate slower than the cells in the control wells, 
but that was not significant either (picture 21).  
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Picture 20, Relative change in the number of migrating cells in kurtoxin wells compared to the 
control after 24 hours of incubation when grown in the presence of 300 nM kurtoxin. 
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Picture 21, relative change in the cell number compared to the beginning when grown in the 
presence of 300 nM kurtoxin. 
 
79 
 
Kurtoxin at 300 nM was added to 2 of wells of a 6-well plate after 2 days of incubation. 
Unfortunately, the differentiation of the cells in these wells was already poor from the 
beginning, so the results were unreliable, and therefore excluded. As it can be seen in 
the picture 24, kurtoxin was added after 48 hours, but the growth curve is showing very 
slow migration rate for many hours before that.    
 
12.1.4 Comparing kurtoxin and ethosuximide to the control 
 
When  the  cells  were  differentiated  in  the  presence  of  kurtoxin  at  300  nM  and  
ethosuximide at 5 mM, the outcome was that ethosuximide had a significant effect in 
decreasing the migration rate of the cells, when measured at 24 hours after starting the 
experiment.  (p  =0.05).  There  was  also  a  difference  between  kurtoxin  and  the  control  
wells,  which  was  not  statistically  significant  (picture  22).  Growth  curves  of  the  cells  
show the same tendency (picture 23.) 
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Picture 22, Relative change in the number of cells migrating after 24 hours of incubation in the 
presence of 300 nM kurtoxin and 5 mM ethosuximide compared to the control. 
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Picture  23,  Cells  grown  in  the  presence  of  5  mM ETX and  300  nM KTX during  70  hours  of  
incubation. 
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Picture 24, Cells count curves. Ethosuximide was added at 36 hours of incubation and kurtoxin 
48 hours after incubation. Differentiation was disturbed in the kurtoxin wells already before 
adding the substance.  
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12.1.5 HEK- cells as a negative control 
 
HEK- cells were used as a negative control because they do not express voltage-
activated calcium channels. By adding the substances to be examined to these cells, 
some information of unspecific cytotoxicity can be gained. The HEK- cells were plated 
on 30 5 milliliters petri- plates containing DMEM- growth medium. 6 plates were used 
as control plates. Ethosuximide 5 mM was added to 6 other plates, as well as mibefradil 
hydrochloride (Tocris Bioscience, USA) 1 µM, manganese (Mn) 10 µM and pimozide 
100 nM. By the time this experiment was made, nickelchloride was already shown to 
have unspecific toxicity on the HEK- cells. First, all the three substances were added to 
three separate plates. The confluence was detected after 24 hours incubation at 37 ?C. It 
was noted that the confluence was 100 % in the control plates (picture 25) and in the 
ethosuximide (picture 26) and mibefradil (picture 27) plates. 
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Picture 26, control cells after 24 hours of incubation 
 
 
Picture 27, ethosuximide treated cells after 24 hours of incubation 
 
 
Picture 28, mibefradil hydrochloride after 24 hours of incubation 
83 
 
Cells in the pimozide (picture 30) and manganese (picture 29) plates were disturbed and 
detached from the bottom of the plate. This shows that these substances have unspecific 
cytotoxicity and effects on something else than voltage-activated calcium channels. 
After incubating the cells 24 hours more, the situation did not change. Control, 
ethosuximide and mibefradil plates were still alike and confluence was not disturbed 
(pictures 31, 32, 33). 
 
 
 
Picture 29, manganese after 24 hours of incubation 
 
 
Picture 30, pimozide after 24 hours of incubation 
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Picture 31, control cells after 48 hours of incubation 
 
Picture 32, ethosuximide treated cells after 48 hours of incubation 
 
Picture 33, mibefradil treated cells after 48 hours of incubation 
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12.2 Immunostaining 
 
12.2.1 Experiment 4: detecting the cells expressing neuronal markers 
 
Immunostaining the cells with Tuj-1, as described in Materials and methods, chapter 
10.2, showed that the cells used in these experiments differentiate and gain some 
neuronal features. This is shown in pictures 35 and 36 that are taken from the cells that 
were differentiated for 5 days (picture 35) and for 7 days (picture 36). In picture 37, 
there is one cell from the spheres that were differentiated for 7 days. In addition to the 
expression  of  ?-tubulin  III,  which  shows  as  a  red  color,  it  has  clear  morphological  
features of a neuronal cell. 
 
 
Pictures 35 and 36, cells differentiated for 5 days are on the left, and the cells differentiated for 
7 days are on the right. Red colored cells in the pictures express ?-tubulin III, a marker of neural 
maturation. 
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Picture 37, a neuronal cell in the culture differentiated for 7 days 
 
12.2.2 Experiment 5: Detecting the cells expressing T-type calcium channels 
 
Another essential thing to prove was that the cells used in these experiments express T-
type calcium channels. Labeling the cells with a T-type specific antibody and imaging 
with confocal microscope revealed that the 87.5 ± 5 % of the cells differentiated for 3 
days, express T-type calcium channels (picture 38). Pictures 38-41 are published with 
permission. 
 
 
Picture 38, 87.5 ± 5 % of the cells differentiated for 3 days expressed T-type calcium channels. 
The image limited with the white bordered box is on the right. 
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The same picture with Tuj-1 antibody shows that the cells also express neuronal 
elements (picture 39). On the right side of picture 39, there is an overlap of T-type 
antibody expressing picture and Tuj-1 picture. That overlap shows two cells with 
smaller somas, which do not express T-type calcium channels as much as the other five 
cells in the overlap picture. 
 
 
Picture 39, cells expressing ?-tubulin III after 3 days of incubation. On the right there is 
an overlap of Tuj-1 and T-type antibody pictures.  The cells that  express both neuronal 
markers and T-type calcium channels are mostly yellow in their color. Two of the cells 
that do not express T-type calcium channels are marked with white arrows. 
 
DAPI, which dyes all the cells somas blue, is shown in the picture 36. On the right side 
of the picture there is an overlap of the pictures with T-type antibody and DAPI. In this 
overlap the cells expressing T-type calcium channels are light blue in their color. 
Picture 40 shows all the cells in the picture. Picture 41 is an overlap of all these pictures.  
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Picture 40, DAPI dyes all the cells somas blue. An overlap of all the pictures where T-type 
channels and other cells are on the right side. 
 
 
Picture 41, an overlap of all the previous pictures showing the cells expressing ?-tubulin III, T-
type calcium channels and all the cells that have somas. 
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13. Conclusions 
 
The results show that all the known blockers of T -type calcium channels added to the 
growth medium decreased the number of cells migrating from the neurospheres. This 
effect was even clearer when the cells were grown in the presence of nickel chloride and 
ethosuximide than when the differentiation was started without pharmacological 
treatment. These two different treatments were conducted to see the difference in 
timing. This reflects the role of low-voltage activated calcium channels in neuronal 
differentiation. It can be assumed that if the role of T-type calcium channel is crucial in 
the very beginning of migration, the specific blockers would have a clearer effect on the 
cells than if added two days later. In the case that T-type calcium channel’s role would 
appear later on, one could expect to see no significant effect of the blockers when added 
right in the beginning of the differentiation. 
The results gained in our studies demonstrate that nickel chloride had the most 
significant effect, although it might also be less selective. The number of the cells when 
they were grown in the presence of nickel chloride was 1.5-fold lower compared to the 
control  than  when  it  was  added  afterwards.  The  ratio  when  grown  in  the  presence  of  
ethosuximide and added afterwards compared to the control was not so clear, with 1.5 
and 1.4-fold difference in the cell number, respectively. Considering that the difference 
in the cell number between the control and ethosuximide treatment when ethosuximide 
was added 24 hours afterwards was not statistically significant, makes the effect more 
questionable at this specific time point. The effect of these substances decreasing the 
cell number when grown in the presence of them might indicate that T-type calcium 
channel has an important role in the early state of the migration. When the antagonists 
are added afterwards, the effect on the cells is not as strong. On the other hand, in our 
experiments kurtoxin produced different effects at this specific time point, although the 
results gained with kurtoxin are not very reliable for two reasons. Firstly, differentiation 
of  the  cells  in  the  kurtoxin  wells,  as  wells  as  in  the  control  wells,  was  disturbed  even  
before adding the compound, and there was no statistical difference compared to the 
control. Secondly, kurtoxin is a peptide toxin, and relatively instable compared to the 
non-peptide compounds. Also other studies have disputed over the results and 
performing of kurtoxin experiments. Kurtoxin has produced very different sets of gating 
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modifications in different calcium channel subtypes in one experiment (Sidach and 
Mintz, 2002). The authors describe these findings as unexpected, and therefore rule out 
the use of kurtoxin in functional studies of T-type calcium channel. At this point it must 
be noted that although the compound is complicated, probably mostly due to its peptide 
structure, failures in one study should not completely exclude the use of this substance 
in functional studies, in my opinion. In another study it was noted that kurtoxin interacts 
with voltage-gated sodium channels (Chuang et al, 1998). After all, in our experiments 
made with kurtoxin, the tendency of the toxin inhibiting cells’ migration was the same 
as in the results gained with nickel and ethosuximide.  
Previous studies done by Komuro and Rakic show that N-type calcium channel would 
play the key role in neuronal migration. In this study we investigated LVA calcium 
channels and saw an effect of T-type calcium channel blockers interfering with the 
migration. Komuro and Rakic showed that blocking of T-type channels did not have a 
significant  effect.  However,  they  studied  the  migration  of  purkinje  cells  which  are  
postnatal. Furthermore, the concentrations used in their studies were different. Komuro 
and Rakic investigated the effect of calcium channel blockers on neuronal migration as 
movements of single cells, while we studied the effect on the whole cell population as a 
number  of  migrating  cells.  They  showed that  the  blockage  of  N-type  calcium channel  
significantly decreases the rate of cell movement (Komuro and Rakic, 1998). They also 
claimed that  blocking  other  types  of  voltage-gated  calcium channels,  such  as  L-  or  T-
type  calcium  channels  had  no  significant  effect.  This  might  be  due  to  the  low  
concentrations of antagonists they used in the experiment. Nickel chloride was used at a 
concentration of 100 µM, while the concentration of nickel chloride in this study was 
ten times higher, 1 mM. This is simply because of the growth medium we used contains 
phosphates  that  buffer  most  of  the  heavy  metals.  It  is  clear  that  the  experimental  
procedures being so different in our study compared to the ones of Komuro and Rakic, 
makes the comparison very difficult. 
 In two other studies L-type calcium channel is shown to promote neuronal 
differentiation  (Gicola  et  al.  1998;  D’Ascenzo  et  al.  2006).  There  are  similar  results  
gained in the research of T-type calcium channel (Chemin J. et al. 2002; 2003). At this 
point, it must be kept in mind that these results do not disagree with the results of 
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Komuro and Rakic, considering that migration and differentiation are classified as 
different events in the neurogenesis, and they are altered mostly by different reactions. 
It is likely that an endogenous factor does not affect a certain phase of neurogenesis but 
promotes another. In the study of Chemin et al, 2002, the authors concluded that T-type 
calcium channels trigger the onset of differentiation and regulate the expression of HVA 
calcium channels. When comparing all these studies to each other a question arises: Is 
there in fact a controversy after all or do we just face the complexity of neuronal 
developmental events and their overlapping nature? Undoubtedly one problem is 
comparing the different experimental set ups to each other. Comparison of the studies 
made with cell cultures and electrophysiological single-cell studies is not entirely 
impossible, but challenging. There are several factors that have to be taken into account, 
including  the  cell  type,  time  and  origin  of  extraction  of  the  cells  and  the  day  of  
differentiation when the records are made, in addition to the concentration and 
selectivity of the test compound, just to list some of the most critical issues. 
In this study, the selectivity of the compound was tested with a negative control, HEK-
cells, which do not express voltage-gated calcium channels. The results were as 
expected. The drugs known to be more selective, ethosuximide and mibefradil had no 
effect on them, while the less selective compounds manganese and pimozide disturbed 
the  growth  of  the  HEK-cells.  In  pictures  29  and  30  this  can  be  seen  as  detached  cell  
aggregates on an above layer of the cells attached to the plate. 
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14. Discussing the results and questions to analyze further 
 
 
This study shows that T-type calcium channel is likely to take part in neuronal 
progenitor cells’ migration. This finding is in line with other studies that show T-type 
calcium channel promoting neurogenesis (Gu and Spitzer, 1993; Chemin et al, 2002; 
2003) and calcium ion being a key regulator in the process of neural induction (Webb et 
al, 2005). T-type selective antagonists, ethosuximide, nickelchloride and kurtoxin 
decreased the rate of migration in mice embryonic subventricular zone progenitor cells. 
The effect was clearer when differentiation of the cells was started in the presence of 
these substances. In contrast, an L-type specific blocker nifedipine and an N-type 
specific blocker ?-conotoxin did not have a significant effect under the same conditions 
(data under inspection). 
There are yet some problems this study could not overcome. One of them is the lack of 
a specific T-type channel antagonist, and these results are based in a statistical 
likelihood of the function of different T-type channel antagonists. The results do not 
conclude that T-type channel’s role in migration would be the most dominant. If 
assumed that T-type channel has a significant role in promoting migration, one would 
conclude, that the more specific the T-type blocking antagonist is, the more it inhibits 
the migration. This study shows conversely results. This in turn gives us a reason to 
consider that the previous assumption made about T-type channel having the biggest 
role  in  migration,  might  be  wrong.  More  likely  it  seems to  be  that  the  T-type  calcium 
channel works together with some other endogenous factors, like for example other 
voltage-activated channels, integrins, and external signals, without any kind of 
hierarchy between them. 
Hence, further studying should be made to confirm the results gained in this study, and 
point out the exact role of T-type calcium channel in migration, and the significance of 
this role. Also the roles of each subtype of the T-type channel remain unsolved. These 
studies could include experiments with gene-experssed cells overexpressing a certain 
subtype.  Three-dimensional  cell  growth  conditions  would  be  the  most  favorable,  
mimicking the cells’ natural environment in the brain. In vivo labeling and detecting of 
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the progenitor cells would give some valuable information of the cells’ migration. An 
urgently needed investigation would be a highly specific T-type calcium channel 
antagonist.  In  addition  to  that  it  would  be  useful  in  the  research  of  T-type  channel’s  
functions it would also be of a great clinical profit in treatment of absence epilepsy.      
What comes to the therapeutic relevance of these findings is that a lot more fundamental 
studying has to be made to achieve the “pharmacological toolkit” to manipulate the 
endogenous stem cells. To generalize, the main problems in stem cell therapies are the 
reciever’s immunity, stem cells’ survival, differentiation, targeted migration, and not 
turning  into  tumors.  One  of  these  barriers  is  already  crossed  with  the  help  of  
pharmacology. Namely, the reciever’s immunity can be stopped from rejecting the cells 
with immunosuppressive medication. 
The challenge, that Santiago Ramón y Cajal casted nearly a century ago for the future 
researchers is overcome. Now that we know that neurogenesis continues in the adult 
brain, has brought us a new question to answere. How can the mankind benefit from the 
stem cells in a cost-effective way that is available for everyone? 
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ATTACHMENT 1: SOLUTIONS 
 
Poly-l-ornithin 
- is used to coat the wells and plates, NSCs attach to the coating  material and start 
their differentiation 
- ordered from Sigma 
 
Poly-l-ornithin is diluted in 25 mg/ 50 ml of PBS and sterile filtered. This solution is 
used in a concentration of 1:10 of PBS, or even more diluted. The solutions are stored in 
-20?C. 
 
1 M HEPES 
- is added in growth medium in 0.75 ml/ 50 ml as a buffer solution 
- the solution has to be autoclaved before use 
- the salt powder ordered from Sigma-Aldrich is added in aqua sterilisata in a 
concentration of 1 M (mol/l): 
 
M = 238g/mol 
V = 500 ml 
m = MCV = 119g 
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PBS 
1 litre of PBS consists of: 
- NaCl2   80.0 
- KCl2   80.0 
- Na2HPO4 x 2 H2O   14.0 
- KH2PO4      2.0 
ad 1 l aqua sterilisata 
 
- pH of the solution needs to be adjusted to 7.3 
- solution must autoclaved 
- the solution is stored in the fridge 
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ATTACHMENT 2: B27 SUPPLEMENT 
 
B27 supplement is prepared in distilled water. The components of the solution are: 
 
- d-biotin 
- BSA 
- l-carnithine 
- corticosterone 
- ethanolamine HCl 
- d-galactose (anhydr.) 
- insulin (human, Zn) 
- linoleic acid 
- progesterone 
- putrescine 2HCl 
- sodium selenite 
- T3/albumin complex 
- transferring (human, iron-) 
 
The solution is stored in -20?C 
